Je apotheker kan meer. Hoe maken we dat mogelijk?

1.    OECD. Health Data Governance: Privacy, Monitoring and Research [Internet].https://www.oecd.org/en/publications/health-data-governance_97892642445… doi:10.1787/9789264244566-en

2.    Pharmaceutical Group of the European Union. A Vision for community pharmacy in Europe [Internet]. Brussels, Belgium: Pharmaceutical Group of the European Union; 2026. Available from: https://www.pgeu.eu/wp-content/uploads/2026/01/PGEU_Vision-.pdf

3.    OECD. Realising the Potential of Primary Health Care [Internet]. OECD; 2020 [cited 2026 Mar 8]. (OECD Health Policy Studies). Available from: https://www.oecd.org/en/publications/realising-the-potential-of-primary… doi:10.1787/a92adee4-en

4.    Muscat NA, Sinclair P, Zapata T, Connolly D, Pinto GS, Kniazkov S. Embracing pharmacists’ roles in health-care delivery. Lancet Reg Health - Eur. 2024 Nov;46:101088. doi:10.1016/j.lanepe.2024.101088

5.    Pharmaceutical Group of the European Union. Report on Pharmacy Services in Europe [Internet]. Brussels, Belgium: Pharmaceutical Group of the European Union; 2025. Available from: https://www.pgeu.eu/wp-content/uploads/2025/09/Report-on-Pharmacy-Servi…

6.    Koudmani D, Bader LR, Bates I. Developing and validating development goals towards transforming a global framework for pharmacy practice. Res Soc Adm Pharm. 2024 Dec;20(12):1118–24. doi:10.1016/j.sapharm.2024.09.002

7.    International Pharmaceutical Federation. FIP Statement of Policy – People-centred pharmaceutical care [Statement of Policy] [Internet]. The Hague: International Pharmaceutical Federation; 2025. Available from: https://www.fip.org/statements

8.    Batista JPB, Weidmann AE, Mallarini E, Henman MC, Passarani I. Evolution of community pharmacy services in the European Union and beyond: a cross-country survey of 33 national pharmacy organisations. Int J Clin Pharm. 2026 Apr 15. doi:10.1007/s11096-026-02137-9

9.    Al Meslamani AZ. The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know? Clin Pharm Connect. 2025 Sep 28;1(1):1. doi:10.69709/CPC.2025.113833

10.   Karia A, Chen L, Norman R, Robinson S, (Griffiths) R, Sim TF. Barriers and facilitators affecting the implementation of community pharmacist–led professional services in Organisation for Economic Co-operation and Development member countries: a scoping review in the context of expanded scope. Int J Pharm Pract. 2025 Dec 8. doi:10.1093/ijpp/riaf120

11.   Calfat AC, Duval C, Laberge M, Savard AM, Sirois C. Clinical services in community pharmacies: a scoping review of policy and social implications. Int J Pharm Pract. 2021;29(2). doi:10.1093/ijpp/riaa007

12.   Atkinson J. Advances in Pharmacy Practice: A Look towards the Future. Pharmacy. 2022 Sep 30;10(5):125. doi:10.3390/pharmacy10050125

13.   World Health Organization. Regional Office for Europe. The legal and regulatory framework for community pharmacies in the WHO European Region [Internet]. Copenhagen: WHO Regional Office for Europe; 2019. Available from: https://iris.who.int/bitstream/handle/10665/326394/9789289054249-eng.pdf

14.   Gomes M, Steurbaut R, Dias H. A Qualitative Study to Explore Global Trends in Clinical Pharmacy Practice. J Eval Clin Pract. 2025 Jun;31(4):e70104. doi:10.1111/jep.70104

15.   International Pharmaceutical Federation. Global Situation Report on Pharmacy 2025: Workforce, Practice and Policy [Global situation report] [Internet]. The Hague: International Pharmaceutical Federation; 2025. Available from: https://www.researchgate.net/profile/Sarah-Dineen-Griffin/publication/3…

16.   OpenAI. ChatGPT [Web application]. San Francisco, CA: OpenAI; 2026 [cited 2026 May 23]. Available from: https://chatgpt.com/

17.   Krols C. Overkoepelende vergelijkingsmatrix van internationale evoluties in de officina-apotheekpraktijk [Internet]. figshare; 2026. Available from: https://figshare.com/articles/dataset/Overkoepelende_vergelijkingsmatri… doi:10.6084/m9.figshare.32588934

18.   Jackson JK, Chaar BB, Kirkpatrick CM, Scahill SL, Mintrom M. A Qualitative Evaluation of the Australian Community Pharmacy Agreement. Pharmacy. 2023 Dec 18;11(6):188. doi:10.3390/pharmacy11060188

19.   Armstrong S. Sector Analysis Report 2025: Quantifying the Economic & Social Value of Community Pharmacy [Sector analysis report] [Internet]. World Pharmacy Council; 2025 Nov. Available from: https://d2s3n99uw51hng.cloudfront.net/static/2025%20Sector%20Analysis%2…

20.   Aly M, García-Cárdenas V, Williams K, Benrimoj SI. A review of international pharmacy-based minor ailment services and proposed service design model. Res Soc Adm Pharm. 2018 Nov;14(11):989–98. doi:10.1016/j.sapharm.2017.12.004

21.   Vogler S, Haasis MA. Medicines Reimbursement Policies in Europe [Internet]. Copenhagen, Denmark: World Health Organization, Regional Office for Europe; 2018. Available from: https://www.researchgate.net/profile/Sabine-Vogler/publication/32665832…

22.   Health New Zealand. Health New Zealand | Te Whatu Ora [Internet]. 2026 [cited 2026 May 24]. Integrated community pharmacy services agreement (ICPSA). Available from: https://www.healthnz.govt.nz/health-professionals/guidance-standards/to…

23.   Ministry of Health (New Zealand). Meeting with Pharmacy Guild of New Zealand Inc. 22 February 2024 [Internet]. Wellington, New Zealand: Ministry of Health (New Zealand); 2024 Feb. Available from: https://www.health.govt.nz/system/files/2025-05/H2024036151-AM-Meeting-…

24.   Moriarty S, Bradford M, Stockwell S, Wu F, Adams A, Richard-Sheridan M, et al. A qualitative evaluation of clinical services under the Community Pharmacy Contractual Framework: Full report [Internet]. Cambridge, United Kingdom: RAND Europe - NHS England; 2025. Report nos: RRA3570-1. Available from: https://www.rand.org/content/dam/rand/pubs/research_reports/RRA3500/RRA…

25.   Balogun B. Community pharmacy in England [Internet]. London: House of Commons Library; 2026 Mar. (Commons Library Research Briefing). Report no.: 9854. Available from: https://researchbriefings.files.parliament.uk/documents/CBP-9854/CBP-98…

26.   Department of Health; Health Service Executive; Irish Pharmacy Union. Community Pharmacy Agreement 2025 [Internet]. Ireland: Department of Health / Health Service Executive; 2025 Sep. Available from: https://about.hse.ie/api/v2/download-file/healthcare_professional_publi…

27.   Indenrigs- og Sundhedsministeriet; Danmarks Apotekerforening. Bruttoavanceaftale 2025-2026 [Internet]. København: Indenrigs- og Sundhedsministeriet; Danmarks Apotekerforening; 2025. Available from: https://www.ism.dk/Media/638737491079424158/Aftale-apo-ISM-2025-26.pdf

28.   Arrêté du 31 mars 2022 portant approbation de la Convention nationale organisant les rapports entre les pharmaciens titulaires d’officine et l’assurance maladie - Légifrance [Internet]. [cited 2026 May 24]. Available from: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000045538155

29.   Caisse Nationale de l’Assurance Maladie (CNAM) / Ameli. Ameli.fr [Internet]. 2025 [cited 2026 May 6]. Nationale Convention des Pharmaciens Titulaires d’Officine. Available from: https://www.ameli.fr/pharmacien/textes-reference/textes-conventionnels/…

30.   Racle G, Variot PO, Bertholom B, Masset C, Auge-Caumon MJ. Pharmaceutical agreement 2022–2027: new missions of French pharmacies. In: Vol. 23. FIP World Congress Brisbane 2023; 2023. Available from: https://uspo.fr/wp-content/uploads/2023/10/2023-09-24-pharmaceutical-ag… doi:10.46542/pe.2023.236.61128

31.   Baird B, Buckingham H, Charles A, Edwards N, Murray R. A Vision for Community Pharmacy [Internet]. London, United Kingdom: The King’s Fund; Nuffield Trust; 2023. Available from: https://www.nuffieldtrust.org.uk/sites/default/files/2023-09/Nuffield%2…

32.   NHS England. Community Pharmacy advanced service specification: NHS Pharmacy First Service (Including the service previously known as the NHS Community Pharmacist Consultation Service (CPCS)) [Internet]. London: NHS England; 2023. Available from: https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN00936-i-Commun…

33.   NHS Business Services Authority. Drug Tariff December 2025 [Government document] [Internet]. Newcastle upon Tyne, United Kingdom: NHS Business Services Authority; 2025. Available from: https://www.nhsbsa.nhs.uk/sites/default/files/2025-11/Drug%20Tariff%20D…

34.   Community Pharmacy England. Community Pharmacy England’s brief guide to the Community Pharmacy Contractual Framework and Funding [Briefing paper] [Internet]. London, United Kingdom: Community Pharmacy England; 2025. Available from: https://cpe.org.uk/wp-content/uploads/2024/06/Community-Pharmacy-Englan…

35.   Yamate M. Update of Drug Pricing System in Japan [Ministry of Health, Labour and Welfare] [Internet]. Ministry of Health, Labour and Welfare presented at. 2018 Jul 3; Tokyo, Japan. Available from: https://www.pmda.go.jp/files/000221888.pdf

36.   Hussain R, Babar ZUD. Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature. J Pharm Policy Pract. 2023 Dec 31;16(1):118. doi:10.1186/s40545-023-00626-0

37.   Peletidi A, Birlirakis V, Petrides M. Strategic infrastructure planning for the evolution of 2030 community pharmacy. J Pharm Policy Pract. 2024 Dec 31;17(1):2421286. doi:10.1080/20523211.2024.2421286

38.   National Alliance of State Pharmacy Associations (NASPA), National Association of Boards of Pharmacy (NABP). Pharmacist Statewide Protocols: Key Elements for Legislative and Regulatory Authority [Internet]. Richmond, VA / Mount Prospect, IL, USA: National Alliance of State Pharmacy Associations; National Association of Boards of Pharmacy; 2017 Mar. Available from: https://naspa.us/wp-content/uploads/2017/03/Pharmacist-Statewide-Protoc…

39.   Orris A, Mauser G, Bachrach D, Craven M. Implementing Pharmacist Contraceptive Prescribing: A Playbook for States and Stakeholders [Internet]. Washington, D.C.: Manatt Health; 2021 Jan. Available from: https://assets-us-01.kc-usercontent.com/9fd8e81d-74db-00ef-d0b1-5d17c12…

40.   Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. Int J Pharm Pract. 2019 Nov 6;27(6):479–89. doi:10.1111/ijpp.12557

41.   Feng Z, Ye Y, Ye H, Tang Z. Changes in pharmaceutical retail market and regional inequality of community pharmacists accessibility in mainland China: a retrospective cross-sectional study. BMJ Open. 2022 Nov;12(11):e063739. doi:10.1136/bmjopen-2022-063739

42.   Tang Z, Lhamu P, Ye H, Hong L, Xiang X. Current Perceptions and Improvement Approaches of Pharmaceutical Care Capacity of Community Pharmacists: A Quantitative Analysis Based on Survey Data at Chinese Chain Pharmacies. Int J Environ Res Public Health. 2020 Oct 14;17(20):7482. doi:10.3390/ijerph17207482

43.   Zhang Y, Zhang W, Deng J, Liu Y, Sun L. Analysis of nationwide availability of negotiated drugs in China’s National Reimbursement Drug List. Front Public Health. 2026 Jan 8;13:1718627. doi:10.3389/fpubh.2025.1718627

44.   Xu Z, Nicholas S, Maitland E, Wang J, Li J, Tan J. Reforming China’s retail prescription medicine purchasing system: evidence from retail pharmacies in Wuhan. BMC Health Serv Res. 2026 Feb 27;26(1):461. doi:10.1186/s12913-026-14233-7

45.   Meng W, Wang Y, Shen J, Yan M, Hu Y, Jiang R. Factors affecting community pharmacists’ capacity to deliver pharmacy services in Zhengzhou, China: a cross-sectional study. BMJ Open. 2024 Oct;14(10):e083104. doi:10.1136/bmjopen-2023-083104

46.   Community Pharmacy England. Briefing 010/25: Funding Settlement for 2024/25 and 2025/26 [Internet]. London, United Kingdom: Community Pharmacy England; 2025. Available from: https://cpe.org.uk/wp-content/uploads/2025/03/Briefing-010.25-Funding-S…

47.   Counihan M, Stein I, Flynn C, O’Regan A, Clarke S, Ledwidge M, et al. Advanced pharmacy service provision in community pharmacy across the United Kingdom and Ireland: A Scoping review. Res Soc Adm Pharm. 2025 May;21(5):287–320. doi:10.1016/j.sapharm.2025.01.011

48.   Assurance Maladie / ameli.fr. ameli.fr [Internet]. Assurance Maladie; 2024 [cited 2026 May 2]. Farmaceutische ondersteuning voor chronisch zieke patiënten: principes en aanpak. Available from: https://www.ameli.fr/pharmacien/sante-prevention/accompagnements/accomp…

49.   Ministère du Travail, de la Santé et des Solidarités (France). Arrêté du 5 juillet 2024 portant approbation de l’avenant n° 1 à la convention nationale du 9 mars 2022 organisant les rapports entre les pharmaciens titulaires d’officine et l’assurance maladie [Internet]. Ministère du Travail, de la Santé et des Solidarités (France); 2024 Jul. Available from: https://www.fresquedelapharmacie.org/ROSP2024.pdf

50.   Ceka A, Juneja B, Tseng O, Zhang W, Kuo IF, Bansback N, et al. Bridging the gap between expanded pharmacy services and payment models: A jurisdictional scan. J Am Pharm Assoc. 2026 Jan;66(1):102989. doi:10.1016/j.japh.2025.102989

51.   Vélez CM, Bhuiya A, Wilson MG. Rapid synthesis: Identifying pharmacist remuneration models for the provision of clinical services [Rapid Synthesis; 30-day response] [Internet]. Hamilton: McMaster Health Forum; 2022 Oct [cited 2026 Apr 9]. Available from: https://www.mcmasterforum.org/docs/default-source/product-documents/rap…

52.   Hughes CA, Breault RR, Hicks D, Schindel TJ. Positioning pharmacists’ roles in primary health care: a discourse analysis of the compensation plan in Alberta, Canada. BMC Health Serv Res. 2017 Dec;17(1):770. doi:10.1186/s12913-017-2734-x

53.   Ontario Ministry of Health, Health Programs and Delivery Division. Executive Officer Notice: Update to Funding for Minor Ailment Services in Ontario Pharmacies [Internet]. Ontario, Canada: Ontario Ministry of Health, Health Programs and Delivery Division; 2023 Oct. Available from: https://www.ontario.ca/files/2026-05/moh-executive-officer-notice-minor…

54.   World Health Organization. Operational Framework for Primary Health Care: Transforming Vision into Action [Draft operational framework] [Internet]. Geneva: World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/primary-health/operational-fram…

55.   Bonnan D, Amouroux F, Aulois-Griot M. Le bilan partagé de médication: intérêt de la mise en place d’un nouveau service pharmaceutique dans la detection de problemes lies aux therapeutiques. Ann Pharm Fr. 2021 Sep;79(5):597–603. doi:10.1016/j.pharma.2021.02.009

56.   Cashin C. Paying For Performance In Healthcare: Implications For Health System Performance And Accountability [Internet]. Maidenhead: McGraw-Hill Education; 2014. 338 p. Available from: https://www.oecd.org/content/dam/oecd/en/publications/reports/2014/10/p…

57.   Sustainability of pharmacist-delivered professional services through viable remuneration models [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation (FIP); 2020 Sep. (FIP Statement of Policy). Available from: https://www.fip.org/file/4934

58.   Ontario Ministry of Health and Long-Term Care. Professional Pharmacy Services Guidebook 3.0: MedsCheck, Pharmaceutical Opinion and Pharmacy Smoking Cessation Program [Internet]. Toronto, Ontario, Canada: Ministry of Health and Long-Term Care, Government of Ontario; 2016. Available from: https://files.ontario.ca/moh-medscheck-professional-pharmacy-services-g…

59.   Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV). Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) [Internet]. [cited 2026 Jun 5]. Begeleiden van chronische patiënten als huisapotheker. Available from: https://www.riziv.fgov.be/nl/professionals/individuele-zorgverleners/ap…

60.   National Medical Products Administration. National Medical Products Administration [Internet]. [cited 2026 Jun 5]. Drug Administration Law of the People’s Republic of China. Available from: https://english.nmpa.gov.cn/2019-09/26/c_773012_2.htm

61.   Ministry of Health, Labour and Welfare, Japan. 患者のための薬局ビジョン 概要 - Pharmacy Vision for Patients: Overview [Internet]. Tokyo. Available from: https://www.mhlw.go.jp/file/06-Seisakujouhou-11120000-Iyakushokuhinkyok…

62.   Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). KNMP-richtlijn Praktijkvoering [Internet]. Den Haag: KNMP; 2022 Sep. Available from: https://www.knmp.nl/media/1881

63.   Yong FR. Provision of Community Pharmacy Services: The Pharmacist Role System, Strain and Identity [Doctor of Philosophy (PhD) Thesis] [Internet]. [Sydney, Australia]: University of Technology Sydney; 2021. Available from: https://opus.lib.uts.edu.au/bitstream/10453/160663/2/02whole.pdf

64.   Abrahamsen B, Burghle AH, Rossing C. Pharmaceutical care services available in Danish community pharmacies. Int J Clin Pharm. 2020 Apr;42(2):315–20. doi:10.1007/s11096-020-00985-7

65.   Airaksinen M, Toivo T, Jokinen L, Savela E, Parkkamäki S, Sandler C, et al. Policy and vision for community pharmacies in Finland: A roadmap towards enhanced integration and reduced costs. Pharm Pract. 2021 Feb 4;19(1):2288. doi:10.18549/PharmPract.2021.1.2288

66.   Health New Zealand. Health New Zealand | Te Whatu Ora [Internet]. 2026 [cited 2026 Jun 1]. Community pharmacies — service documents. Available from: https://www.healthnz.govt.nz/health-professionals/guidance-standards/to…

67.   Canadian Pharmacists Association. Pharmacists’ scope of practice in Canada [Internet]. Ottawa, ON: Canadian Pharmacists Association; 2025 [cited 2026 Jun 4]. Available from: https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/Scope…

68.   Schulz M, Griese-Mammen N, Müller U. Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain. Int J Clin Pharm. 2023 Feb;45(1):245–9. doi:10.1007/s11096-022-01492-7

69.   China Food and Drug Administration (CFDA). Good Supply Practice for Pharmaceutical Products (GSP) / 药品经营质量管理规范 [Internet]. Beijing, China: China Food and Drug Administration (CFDA); 2016 Jun. Available from: https://www.bjfsh.gov.cn/ztzx/wqzt/zdlyzfgkzt/qjqd/spypaq/202307/P02023…

70.   Buss VH, Shield A, Kosari S, Naunton M. The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature. J Pharm Policy Pract. 2018 Dec;11(1):22. doi:10.1186/s40545-018-0149-7

71.   MacKeigan LD, Ijaz N, Bojarski EA, Dolovich L. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies. Res Soc Adm Pharm. 2017 Sep;13(5):947–58. doi:10.1016/j.sapharm.2017.03.057

72.   Australian Government Department of Health and Aged Care. Fifth Report on Key Performance Measures (KPM) for the Seventh Community Pharmacy Agreement (7CPA) [Internet]. Canberra, ACT, Australia: Department of Health and Aged Care, Australian Government; 2024. (Key Performance Measures Reports for the Seventh Community Pharmacy Agreement (7CPA)). Available from: https://www.health.gov.au/sites/default/files/2024-07/fifth-report-on-k…

73.   Pharmacy Programs Administrator. Pharmacy Programs Administrator [Internet]. Australian Healthcare Associates; [cited 2026 Feb 21]. MedsCheck and Diabetes MedsCheck. Available from: https://www.ppaonline.com.au/programs/medication-management-programs/me…

74.   Imfeld-Isenegger TL, Soares IB, Makovec UN, Horvat N, Kos M, Van Mil F, et al. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration. Res Soc Adm Pharm. 2020 Aug;16(8):1057–66. doi:10.1016/j.sapharm.2019.11.002

75.   International Pharmaceutical Federation (FIP). The FIP vaccination reference guide: Knowledge and skills to support professional development and inform pharmacy education in vaccination [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation (FIP); 2022. Available from: https://www.fip.org/file/5158

76.   Formoso SO, Strader A, Margheri F. A Call for Comprehensive EU Action on Medication Waste and Management [Position paper] [Internet]. Brussels, Belgium: European Health Management Association; 2026 Feb. Available from: https://ehma.org/app/uploads/2026/02/MediWaste-Position-Paper_02.2026.p…

77.   Mansell K, Bootsman N, Kuntz A, Taylor J. Evaluating pharmacist prescribing for minor ailments. Int J Pharm Pract. 2015 Mar 10;23(2):95–101. doi:10.1111/ijpp.12128

78.   Hazen ACM, Wal AWVD, Sloeserwij VM, Zwart DLM, Gier JJD, Wit NJD, et al. Controversy and consensus on a clinical pharmacist in primary care in the Netherlands. Int J Clin Pharm. 2016 Oct;38(5):1250–60. doi:10.1007/s11096-016-0360-z

79.   Kempen TGH, Benaissa Y, Molema H, Valk LE, Hazen ACM, Heringa M, et al. Pharmacists’ current and potential prescribing roles in primary care in the Netherlands: a case study. J Interprof Care. 2024 Sep 2;38(5):787–98. doi:10.1080/13561820.2024.2374017

80.   Kallio S, Eskola T, Pohjanoksa-Mäntylä M, Airaksinen M. Medication Risk Management in Routine Dispensing in Community Pharmacies. Int J Environ Res Public Health. 2020 Nov 5;17(21):8186. doi:10.3390/ijerph17218186

81.   Iwata M, Maezawa M, Miyasaka K, Hirofuji S, Suzuki T, Nakao S, et al. Survey of community and hospital pharmacist involvement in outpatient chemotherapy using Japanese health information data. J Pharm Policy Pract. 2024 Dec 31;17(1):2286350. doi:10.1080/20523211.2023.2286350

82.   Cai Y, Lei W, Jin Z, Zou J, Xiao J, Feng D. Evaluating China’s pharmaceutical services policies: An integration of policy tools and policy modeling consistency index analysis. Pharmacoeconomics Policy. 2025 Jun;1(2):92–9. doi:10.1016/j.pharp.2025.05.002

83.   Overeenkomst tussen de apothekers en de verzekeringsinstellingen | RIZIV [Internet]. [cited 2026 May 10]. Available from: https://www.riziv.fgov.be/nl/professionals/individuele-zorgverleners/ap…

84.   Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV). Overeenkomst tussen de apothekers en ziekenfondsen [Internet]. Brussels, Belgium: RIZIV; 2022 Jan. Available from: https://www.riziv.fgov.be/SiteCollectionDocuments/overeenkomst_apotheke…

85.   Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG). FAGG [Internet]. 2026 [cited 2026 May 18]. Vestiging van apotheken en het kadaster van voor het publiek opengestelde apotheken. Available from: https://www.fagg-afmps.be/nl/MENSELIJK_gebruik/geneesmiddelen/geneesmid…

86.   Orde der Apothekers (Nationale Raad). Memorandum 2024 [Internet]. Brussel, België: Orde der Apothekers – Nationale Raad; 2024. Available from: https://ordederapothekers.be/sites/default/files/uploads/2026-02/Memora…

87.   Organisation for Economic Co-operation and Development (OECD), European Observatory on Health Systems and Policies. State of Health in the EU: Belgium – Country Health Profile 2025 [Internet]. Paris / Brussels: OECD Publishing; European Observatory on Health Systems and Policies; 2025. (State of Health in the EU). Available from: https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/12/c…

88.   MacLeod-Glover N. An explanatory policy analysis of legislative change permitting pharmacists in Alberta, Canada, to prescribe. Int J Pharm Pract. 2011 Jan 14;19(1):70–8. doi:10.1111/j.2042-7174.2010.00074.x

89.   Czarniak P, Krass I, Sunderland B, Sim TF, Carter S. Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies. Res Soc Adm Pharm. 2021 Sep;17(9):1614–22. doi:10.1016/j.sapharm.2020.12.014

90.   Australian Government Department of Health and Aged Care. Impact Analysis: Negotiation of New Community Pharmacy Agreement [Internet]. Canberra, ACT: Australian Government Department of Health and Aged Care; 2024. Report nos: OIA23-05019. Available from: https://oia.pmc.gov.au/sites/default/files/posts/2024/06/Impact%20Analy…

91.   Vergoeding van de apothekers in een voor het publiek opengestelde apotheek | RIZIV [Internet]. [cited 2026 May 10]. Available from: https://www.riziv.fgov.be/nl/professionals/individuele-zorgverleners/ap…

92.   Tobback E, De Wulf I, Wauters E, Mendez Santos D, Patris S, Dalleur O, et al. Implementation of medication review type 2a in community pharmacies: a longitudinal survey study. Front Pharmacol. 2025 Nov 12;16:1685922. doi:10.3389/fphar.2025.1685922

93.   Van De Pol JM. The Changing Face of Community Pharmacy Practice: Increasing time for our priorities [Internet]. Utrecht University; 2021 [cited 2026 Apr 26]. Available from: https://dspace.library.uu.nl/handle/1874/405075 doi:10.33540/773

94.   Fynn J, Lamptey M, Coote G, Twigg MJ, Newman J, Lingard S, et al. A mixed methods evaluation of a shared electronic health record between general practice and community pharmacy. Int J Clin Pharm. 2025 Aug 7;48(1):148–59. doi:10.1007/s11096-025-01972-6

95.   Hossain LN, Tudball J, Franco-Trigo L, Durks D, Benrimoj SI, Sabater-Hernández D. A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level. Res Soc Adm Pharm. 2018 Aug;14(8):765–75. doi:10.1016/j.sapharm.2017.10.001

96.   Pharmaceutical Group of the European Union. Pharmacy 2030: A Vision for Community Pharmacy in Europe [Position paper / Vision paper] [Internet]. Brussels, Belgium: Pharmaceutical Group of the European Union; 2019. Available from: https://www.pgeu.eu/wp-content/uploads/2019/03/Pharmacy-2030_-A-Vision-…

97.   Interministeriële Conferentie Volksgezondheid. Protocolakkoord: Actieplan e-Gezondheid 2022–2024 [Internet]. Brussel: RIZIV / INAMI; 2022. Available from: https://www.riziv.fgov.be/SiteCollectionDocuments/actieplan_2022_2024_e…

98.   Weir NM, Newham R, Dunlop E, Bennie M. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research. Implement Sci. 2019 Dec;14(1):21. doi:10.1186/s13012-019-0867-5

99.   Henman MC, Ravera S, Lery FX. Council of Europe Resolution on the Implementation of Pharmaceutical Care—A Step Forward in Enhancing the Appropriate Use of Medicines and Patient-Centred Care. Healthcare. 2024 Jan 17;12(2):232. doi:10.3390/healthcare12020232

100. Deloitte. Pharmacy Programs Cost Effectiveness Review: Final Report – Health/E24-251563 [Final report] [Internet]. Australia: Deloitte; 2025 Jun. Available from: https://www.health.gov.au/sites/default/files/2025-12/pharmacy-programs…

101. Iketani R, Konomura K. Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database. BMC Health Serv Res. 2022 Dec;22(1):682. doi:10.1186/s12913-022-08093-0

102. Julian S, Morris J, Scobie S. Independent Prescribing in the UK: Workforce Ambitions and Implementation Challenges [Research report] [Internet]. London: Nuffield Trust; 2026 Apr [cited 2026 May 26]. Available from: https://www.nuffieldtrust.org.uk/sites/default/files/2026-04/Nuffield%2…

103. Lewis R. Community Pharmacy in Scotland and Wales [Supplementary material] [Internet]. London: Nuffield Trust; 2023 Sep. Available from: https://www.nuffieldtrust.org.uk/sites/default/files/2023-09/Community%…

104. Pharmaceutical Group of the European Union. Pharmacists Workforce Shortages [Position paper] [Internet]. Brussels, Belgium: Pharmaceutical Group of the European Union; 2024. Available from: https://www.pgeu.eu/wp-content/uploads/2024/11/PGEU-position-on-Pharmac…

105. Connelly D. Special report: the stressors burning out pharmacists. Pharm J. 2024 Aug 22;313(7988). doi:10.1211/PJ.2024.1.324833

106. Officer T, McDonald J, Jeffreys M, Cumming J, Russell L, McKinlay E, et al. Changes in provision of extended community pharmacy services in Aotearoa New Zealand, 2018 to 2022. BMC Health Serv Res. 2024 Dec 18;24(1):1571. doi:10.1186/s12913-024-11948-3

107. Ganer T. Halvdelen af apotekerne har ubesatte farmakonomstillinger. Farmaci [Internet]. 2022 May;(05). Available from: https://www.apotekerforeningen.dk/media/lwmjdvry/farmaci_05_2022.pdf

108. The economics of medication safety: Improving medication safety through collective, real-time learning [OECD Health Working Papers] [Internet]. Vol. 147. 2022 Sep [cited 2026 Feb 22]. (OECD Health Working Papers). OECD Health Working Papers no.: 147. Available from: https://www.oecd.org/en/publications/the-economics-of-medication-safety… doi:10.1787/9a933261-en

109. World Health Organization, International Pharmaceutical Federation. Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: Forty-fifth Report [Internet]. Geneva: World Health Organization; 2011. (WHO Technical Report Series; no. 961). Available from: https://www.who.int/docs/default-source/medicines/norms-and-standards/g…

110. Aharaz A, Kejser CL, Poulsen MW, Jeftic S, Ulstrup-Hansen AI, Jørgensen LM, et al. Optimization of the Danish National Electronic Prescribing System to Improve Patient Safety: Development of a User-Friendly Prototype of the Digital Platform Shared Medication Record. Pharmacy. 2023 Feb 22;11(2):41. doi:10.3390/pharmacy11020041

111. Vehko T. E-health and e-welfare of Finland: Check Point 2022 [Report] [Internet]. Helsinki, Finland: Finnish Institute for Health and Welfare; 2022. Report no.: 6/2022. Available from: https://www.julkari.fi/server/api/core/bitstreams/2cfd1d5f-662c-4949-99…

112. Waterbley P. Advies Hoge Raad Artsen d.d. 5 juni 2025 betreffende de bevoegdheden van de apothekers (actief in publieke officina’s) [Internet]. Brussel, België: Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu; 2025 Jun. Available from: https://overlegorganen.gezondheid.belgie.be/sites/default/files/documen…

113. MUUSMANN. Dosispakket medicin – en analyse [Rapport / Analyse] [Internet]. KL; Danske Regioner; 2023 Jan. Available from: https://www.kl.dk/media/iwnam2yi/dosispakket-medicin-hovedrapport.pdf

114. Irwin AN, Marciniak MW, Awad R, Cadiz CL, Cook SG, Herbert SMC, et al. Interprofessional team‐based care in the community pharmacy setting: A summary of existing models and best practice recommendations. JACCP J Am Coll Clin Pharm. 2024 Oct;7(10):1056–67. doi:10.1002/jac5.2021

115. Löffler C, Koudmani C, Böhmer F, Paschka SD, Höck J, Drewelow E, et al. Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study. BMC Health Serv Res. 2017 Dec;17(1):224. doi:10.1186/s12913-017-2157-8

116. Damiaens A, Fraeyman J, Fakroune S, Hutsebaut C, Roussel S, Van Dyck L, et al. General Practitioners and Community Pharmacists’ Collaboration in Primary Care: Small Steps for a Major Change. Int J Integr Care. 2021 Apr 23;21(2):10. doi:10.5334/ijic.5612

117. Australian Government Department of Health, Disability and Ageing. Aged Care On-site Pharmacist Measure: Pharmacist and Residential Aged Care Home Guide [Internet]. Canberra, ACT, Australia: Australian Government Department of Health, Disability and Ageing; 2025 Jul. Available from: https://www.health.gov.au/sites/default/files/2025-07/aged-care-on-site…

118. Sudeshika T, Naunton M, Deeks LS, Thomas J, Peterson GM, Kosari S. General practice pharmacists in Australia: A systematic review. Rajiah K, editor. PLOS ONE. 2021 Oct 14;16(10):e0258674. doi:10.1371/journal.pone.0258674

119. Morvan L, Peyron C. Pharmaciens et actions pharmaceutiques en Maisons de santé pluriprofessionnelles : modalités et conditions d’interventions innovantes [Internet]. France: HAL open science; 2025. Available from: https://hal.science/hal-05534171v1

120. Heida JP, Brocken E, Rijken J, Keijzer A. Passende farmaceutische zorg: Een onderzoek naar de toekomst van passende farmaceutische zorg in de eerste lijn [Onderzoeksrapport] [Internet]. Utrecht: SiRM; AKD; 2022 Oct. Available from: https://www.sirm.nl/docs/Mosadex-passende-farmaceutische-zorg-eindrappo…).

121. Van De Pol JM, Van Dijk L, Koster ES, De Jong J, Bouvy ML. How does the general public balance convenience and cognitive pharmaceutical services in community pharmacy practice. Res Soc Adm Pharm. 2021 Mar;17(3):606–12. doi:10.1016/j.sapharm.2020.05.014

122. Soares IB, Imfeld-Isenegger TL, Makovec UN, Horvat N, Kos M, Arnet I, et al. A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe. Res Soc Adm Pharm. 2020 Jan;16(1):41–7. doi:10.1016/j.sapharm.2019.02.002

123. Hirota N, Okamura N. Patients’ Attitudes, Awareness, and Opinions About Community Pharmacies in Japan: Next Steps for the Health Support Pharmacy System. Integr Pharm Res Pract. 2020 Nov;Volume 9:243–56. doi:10.2147/IPRP.S275288

124. Faruquee CF, Guirguis LM. A scoping review of research on the prescribing practice of Canadian pharmacists. Can Pharm J Rev Pharm Can. 2015 Nov;148(6):325–48. doi:10.1177/1715163515608399

125. Dinh T, Stonebridge C, Brichta J. A Review of Pharmacy Services in Canada and the Health and Economic Evidence [Research report] [Internet]. The Conference Board of Canada; 2016 Feb. Available from: https://www.pharmacists.ca/cpha-ca/assets/file/cpha-on-the-issues/pharm…

126. Nakai K. Evaluation of new reimbursement fee for care of pharmacists in Japan. Pharm Pharmacol Int J. 2018 Aug 9;6(4). doi:10.15406/ppij.2018.06.00194

127. Bader LR, Bates I, Galbraith K. Trends in advanced practice and specialisation in the global pharmacy workforce: a synthesis of country case studies. Int J Pharm Pract. 2020 Mar 16;28(2):182–90. doi:10.1111/ijpp.12612

128. Scottish Government. Achieving Excellence in Pharmaceutical Care: A Strategy for Scotland [Internet]. Edinburgh, Scotland: Scottish Government; 2017. Available from: https://www.communitypharmacy.scot.nhs.uk/media/1378/2078-08-21-ae_phar…

129. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). Toekomstvisie Openbare Farmacie 2025: Goede farmaceutische zorg in de buurt [Internet]. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP); 2020 Nov. Available from: https://www.knmp.nl/sites/default/files/2022-01/KNMP%20Toekomstvisie%20…

130. Vlaams Apothekers Netwerk (VAN). Jaarverslag 2024 [Internet]. Brussel, België: Vlaams Apothekers Netwerk (VAN); 2025. Available from: https://vlaamsapothekersnetwerk.be/sites/default/files/2025-01/Jaarvers…

131. Royal Pharmaceutical Society (RPS) Scotland. Pharmacy 2030: A Vision for Community Pharmacy [Internet]. Edinburgh, Scotland: Royal Pharmaceutical Society (RPS) Scotland; 2021 [cited 2026 Apr 4]. Available from: https://pharmaceutical-journal.com/article/news/rps-scotland-consults-o…

132. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). Visie preventie door de openbaar apotheker [Internet]. Den Haag, Nederland: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP); 2022 Jul [cited 2026 May 22]. Available from: https://www.knmp.nl/media/1770

133. International Pharmaceutical Federation. The FIP Global Roadmap 2030: Sustainable Advancement for Pharmacy Worldwide [High-level report / Global roadmap] [Internet]. The Hague: International Pharmaceutical Federation; 2022. Available from: https://developmentgoals.fip.org/wp-content/uploads/2022/09/FIP_roadmap…

134. Chen SF, Alyakin A, Seas A, Yang E, Choi JJ, Lee JV, et al. LLM-assisted systematic review of large language models in clinical medicine. Nat Med. 2026 Mar;32(3):1152–9. doi:10.1038/s41591-026-04229-5

135. Gottweis J, Weng WH, Daryin A, Tu T, Sirkovic P, Myaskovsky A, et al. Accelerating scientific discovery with Co-Scientist. Nature. 2026 May 19. doi:10.1038/s41586-026-10644-y

136. Asai A, He J, Shao R, Shi W, Singh A, Chang JC, et al. Synthesizing scientific literature with retrieval-augmented language models. Nature. 2026 Feb 26;650(8103):857–63. doi:10.1038/s41586-025-10072-4

137. LI S. 我国互联网+背景下医院O2O药学服务模式发展研究. 中国药房杂志. 2021;32(4):496. doi:10.6039/j.issn.1001-0408.2021.04.18

138. Mesbahi Z, Piquer-Martinez C, Benrimoj SI, Martinez-Martinez F, Amador-Fernandez N, Zarzuelo MJ, et al. Pharmacists as independent prescribers in community pharmacy: A scoping review. Res Soc Adm Pharm. 2025 Mar;21(3):142–53. doi:10.1016/j.sapharm.2024.12.008

139. Pharmaceutical Group of the European Union. The role of community pharmacists in vaccination [Position paper] [Internet]. Pharmaceutical Group of the European Union; 2023. Available from: https://www.pgeu.eu/wp-content/uploads/2023/11/The-role-of-community-ph…

140. Abdulselam M, El-Awaisi A, Nasr ZG, Shaar S, El Hajj MS. Barriers and facilitators for pharmacist-led vaccination services: A systematic review using the Consolidated Framework for Implementation Research (CFIR). Explor Res Clin Soc Pharm. 2026 Mar;21:100687. doi:10.1016/j.rcsop.2025.100687

141. Owen-Boukra E, Cai Z, Duddy C, Fudge N, Hamer-Hunt J, Husson F, et al. Collaborative and integrated working between general practice and community pharmacies: A realist review of what works, for whom, and in which contexts. J Health Serv Res Policy. 2025 Apr;30(2):136–48. doi:10.1177/13558196241290923

142. Urionagüena A, Piquer-Martinez C, Benrimoj SI, Calvo B, Garcia-Cardenas V, Martinez-Martinez F, et al. Community pharmacy & primary care integration: qualitative study on stakeholders’ opinions and interventions. J Pharm Policy Pract. 2024 Dec 31;17(1):2395551. doi:10.1080/20523211.2024.2395551

143. International Pharmaceutical Federation. Workforce Sustainability and Supporting Positive Practice in Community Pharmacy: An International Report by the FIP Community Pharmacy Section [International report] [Internet]. The Hague: International Pharmaceutical Federation; 2023. Available from: https://www.fip.org/file/5641

144. Hämeen-Anttila K, Mikkola H. Is there a need for standardization of medication counseling in community pharmacies? Res Soc Adm Pharm. 2024 May;20(5):547–52. doi:10.1016/j.sapharm.2024.02.005

145. Coenen I, De Baetselier E, Foulon V, Dilles T. Implementation of interprofessional pharmaceutical care initiatives: lessons learned from successful bottom-up initiatives in primary care. Int J Integr Care. 2024 Apr 9;24:5. doi:10.5334/ijic.7581

146. Hindi AMK, Campbell SM, Jacobs S, Schafheutle EI. Developing a quality framework for community pharmacy: a systematic review of international literature. BMJ Open. 2024 Feb;14(2):e079820. doi:10.1136/bmjopen-2023-079820

147. Inshutiyimana S, Ghanem L, Ramadan N, Hammoud D, Wojtara M, Mshaymesh S, et al. Enhancing patient care: pharmacotherapeutic monitoring in community pharmacies – a literature review. Ann Med Surg. 2025 Mar;87(3):1446–53. doi:10.1097/MS9.0000000000003039

148. Karim L, McIntosh T, Jebara T, Cunningham S. A scoping review of evidence of community pharmacist independent prescribing for common clinical conditions: beyond protocol prescribing. Int J Pharm Pract. 2025 Nov 30;33(6):597–612. doi:10.1093/ijpp/riaf063

149. Moura L, Steurbaut S, Salvesen Blix H, Addison B, Rabus S, Mota-Filipe H, et al. A cross-sectional survey to map Clinical Pharmacy Education and Practice in Europe. Int J Clin Pharm. 2022 Feb;44(1):118–26. doi:10.1007/s11096-021-01321-3

150. Nova Scotia Pharmacy Regulator. Standards of Practice: Prescribing Drugs [Standards of practice / Regulatory standards] [Internet]. Nova Scotia, Canada: Nova Scotia Pharmacy Regulator; 2024 Dec. Available from: https://nspharmacy.ca/wp-content/uploads/SOP_PrescribingDrugs_May2024.p…

151. Paloumpi E, Ozieranski P, Watson MC, Jones MD. Professional and governmental policy on community pharmacy: A 10-year policy review and comparative analysis (2008–2017). Explor Res Clin Soc Pharm. 2023 Sep;11:100298. doi:10.1016/j.rcsop.2023.100298

152. Dineen-Griffin S, Benrimoj SI, Garcia-Cardenas V. Primary health care policy and vision for community pharmacy and pharmacists in Australia. Pharm Pract. 2020 May 15;18(2):1967. doi:10.18549/PharmPract.2020.2.1967

153. Jackson JK, Kirkpatrick CM, Scahill SL, Mintrom M, Chaar BB. Relevance of the community pharmacy policy environment to pharmacists’ performance, as reflected in stakeholders’ perspectives on professionalism and standards. Explor Res Clin Soc Pharm. 2024 Dec;16:100499. doi:10.1016/j.rcsop.2024.100499

154. Jackson JK, Scahill SL, Mintrom M, Kirkpatrick CM. An evaluation of the Australian Community Pharmacy Agreement from a public policy perspective: industry policy cloaked as health policy? J Pharm Policy Pract. 2023 Dec 31;16(1):71. doi:10.1186/s40545-023-00571-y

155. Hermansyah A, Pitaloka D, Sainsbury E, Krass I. Prioritising recommendations to advance community pharmacy practice. Res Soc Adm Pharm. 2018 Dec;14(12):1147–56. doi:10.1016/j.sapharm.2018.02.003

156. Sepp K, Lubi K, Rass H, Volmer D. Provision of community pharmacy services during the first wave of COVID-19 pandemic in Estonia – experiences and future implications. Vilka L, Vike J, editors. SHS Web Conf. 2022;131:02005. doi:10.1051/shsconf/202213102005

157. Melton B, Lai Z. Review of community pharmacy services: what is being performed, and where are the opportunities for improvement? Integr Pharm Res Pract. 2017 Mar;Volume 6:79–89. doi:10.2147/IPRP.S107612

158. OECD. Health at a Glance 2023: OECD Indicators [Internet]. OECD Publishing; 2023 [cited 2026 Mar 8]. (Health at a Glance). Available from: https://www.oecd.org/en/publications/health-at-a-glance-2023_7a7afb35-e… doi:10.1787/7a7afb35-en

159. Sirimsi MM, De Loof H, Van Den Broeck K, De Vliegher K, Pype P, Remmen R, et al. Scoping review to identify strategies and interventions improving interprofessional collaboration and integration in primary care. BMJ Open. 2022 Oct;12(10):e062111. doi:10.1136/bmjopen-2022-062111

160. Australian Government Department of Health and Aged Care. New Payments under the Eighth Community Pharmacy Agreement [Fact Sheet] [Internet]. Canberra, ACT, Australia: Australian Government Department of Health and Aged Care; 2024. Available from: https://www.health.gov.au/sites/default/files/2025-06/new-payments-unde…

161. Commonwealth of Australia, Pharmacy Guild of Australia, Pharmaceutical Society of Australia. Seventh Community Pharmacy Agreement [Internet]. Canberra, ACT, Australia: Australian Government Department of Health; 2020 Jun. Available from: https://www.guild.org.au/__data/assets/pdf_file/0028/93655/20200611-7CP…

162. King S, Scott WJ, Watson J. Review of Pharmacy Remuneration and Regulation: Final Report [Internet]. Canberra, ACT: Commonwealth of Australia; 2017. Available from: https://apo.org.au/sites/default/files/resource-files/2018-05/apo-nid14…

163. Commonwealth of Australia, Pharmaceutical Society of Australia (PSA). Strategic Agreement on Pharmacist Professional Practice [Internet]. Canberra, ACT, Australia: Australian Government Department of Health and Aged Care; 2024 Jun. Available from: https://www.health.gov.au/sites/default/files/2024-06/strategic-agreeme…

164. Pharmacy Programs Administrator. Pharmacy Programs Administrator General Terms and Conditions [Internet]. Melbourne, VIC, Australia: Pharmacy Programs Administrator; 2025. Available from: https://www.ppaonline.com.au/wp-content/uploads/2019/01/Pharmacy-Progra…

165. Australian Government Department of Health, Disability and Ageing. A Guide to Australian Government Payments [Internet]. Canberra, ACT, Australia: Services Australia; 2022 Dec. Available from: https://www.servicesaustralia.gov.au/sites/default/files/2022-11/co029-…

166. Australian Government Department of Health, Disability and Ageing. Australian Government Department of Health, Disability and Ageing [Internet]. Australian Government Department of Health, Disability and Ageing; 2025 [cited 2026 May 28]. Pharmacy Location Rules. Available from: https://www.health.gov.au/committees-and-groups/australian-community-ph…

167. Pharmacy Board of Australia. Pharmacy Board of Australia Guidelines: Quick Reference Guide to Pharmacy Board Guidelines [Internet]. Melbourne, VIC, Australia: Pharmacy Board of Australia. Available from: https://www.pharmacyboard.gov.au/Codes-Guidelines.aspx

168. Australian Health Practitioner Regulation Agency - Home [Internet]. [cited 2026 May 28]. Available from: https://www.ahpra.gov.au/

169. Australian Pharmacy Council (APC). Pharmacist Capability Framework: Consultation Paper – Public Consultation [Internet]. Canberra, ACT, Australia: Australian Pharmacy Council (APC); 2025 Oct. Available from: https://www.pharmacycouncil.org.au/Consultations/Pharmacist-Capability-…

170. Consumers Health Forum of Australia [Internet]. [cited 2026 May 28]. Consumers Health Forum of Australia. Available from: https://www.chf.org.au/

171. National Aboriginal Community Controlled Health Organisation. NACCHO Key Facts [Internet]. Canberra, ACT, Australia: National Aboriginal Community Controlled Health Organisation; 2024. Available from: https://www.naccho.org.au/app/uploads/2024/12/NAC_NACCHOKeyFacts_241125…

172. Australian Digital Health Agency [Internet]. [cited 2026 May 28]. Available from: https://www.digitalhealth.gov.au/australian-digital-health-agency

173. Op De Beeck E, Ledegen H, Slechten G, Van Olmen J, De Loof H, Bastiaens H, et al. Understanding challenges in healthcare access: qualitative insights from healthcare providers and people living in socio-economically vulnerable circumstances. Int J Equity Health. 2025 Oct 8;24(1):259. doi:10.1186/s12939-025-02613-0

174. Federale Raad voor de Apothekers (Conseil Fédéral des Pharmaciens). Advies van de Federale Raad voor de Apothekers betreffende de uitbreiding van de bevoegdheden / Avis du Conseil Fédéral des Pharmaciens concernant l’élargissement des compétences [Advisory report] [Internet]. Brussel, België: FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu – Directoraat-generaal Gezondheidszorg; 2025 Jun. Available from: https://overlegorganen.gezondheid.belgie.be/sites/default/files/documen…

175. Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV). Tarieven: Specialiteiten en andere farmaceutische verstrekkingen – 01-01-2026 [Internet]. Brussel, België: Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV); 2025 Dec. (Omzendbrief VI nr. 2025/352). Report no.: 2025/352. Available from: https://www.riziv.fgov.be/SiteCollectionDocuments/tarief_farmaceutische…

176. Derdebetalersregeling: betaal alleen uw deel, het ziekenfonds vergoedt de zorgverlener rechtstreeks | RIZIV [Internet]. [cited 2026 May 28]. Available from: https://www.riziv.fgov.be/nl/thema-s/verzorging-kosten-en-terugbetaling…

177. Algemene Pharmaceutische Bond (APB). APB [Internet]. 2024 [cited 2026 May 18]. Missie en visie APB. Available from: https://www.apb.be/nl-BE/Artikel/missie-en-visie-apb~1485NL

178. Ophaco – Pharma Phorum [Internet]. [cited 2026 May 21]. Available from: https://www.pharmaforum.be/nl/exhibitor/ophaco/

179. Alberta Health. Ministerial Order 615/2024: Compensation Plan for Pharmacy Services [Internet]. Edmonton, Alberta, Canada: Government of Alberta; 2024 Oct. Report M.O. 615/2024. Available from: https://kings-printer.alberta.ca/Documents/MinOrders/2024/Health/2024_6…

180. Alberta Blue Cross. A Pharmacist’s Guide to Pharmacy Services Compensation [Internet]. Edmonton, Alberta, Canada: Alberta Blue Cross; 2025. Available from: https://www.ab.bluecross.ca/pdfs/pharmacy-services-compensation-guide.p…

181. Office of the Auditor General of Ontario. Ontario Public Drug Programs. In: Annual Report 2017 [Internet]. Toronto, Ontario, Canada: Office of the Auditor General of Ontario; 2017. Available from: https://www.auditor.on.ca/en/content/annualreports/arreports/en17/v1_30…

182. Harris J, Argáez C. Community Pharmacist–Led Medication Reviews. Can J Health Technol. 2021 Jul 27;1(7). doi:10.51731/cjht.2021.102

183. Ontario College of Pharmacists. About the College – OCP website [Internet]. [cited 2026 May 28]. Available from: https://ocpinfo.com/about/about-the-college-and-the-profession/

184. Alberta College of Pharmacy. Standards of Practice for Pharmacists and Pharmacy Technicians [Internet]. Edmonton, Alberta, Canada: Alberta College of Pharmacy; 2025. Available from: https://abpharmacy.ca/wp-content/uploads/Standards_SPPPT.pdf

185. About NAPRA: Short Introductory Presentation - NAPRA [Internet]. 2025 [cited 2026 May 28]. Available from: https://www.napra.ca/about-napra-short-introductory-presentation/

186. Canadian Pharmacists Association (CPhA). CPhA Strategic Plan 2024–2026 [Internet]. Ottawa, ON, Canada; 2024. Available from: https://www.pharmacists.ca/cpha-ca/assets/File/about-cpha/strategic-pla…

187. Terry D, Phan H, Peck B, Hills D, Kirschbaum M, Bishop J, et al. Factors contributing to the recruitment and retention of rural pharmacist workforce: a systematic review. BMC Health Serv Res. 2021 Dec;21(1):1052. doi:10.1186/s12913-021-07072-1

188. Neighbourhood Pharmacy Association of Canada. Impact Report 2024: Thriving Together for Tomorrow: Global Vision and Local Action [Internet]. Toronto, ON, Canada: Neighbourhood Pharmacy Association of Canada; 2024. Available from: https://neighbourhoodpharmacies.ca/sites/default/files/2025-03/2024%20I…

189. CCAPP-Annual-Report-2024-2025 [Internet]. Available from: https://ccapp.ca/wp-content/uploads/2025/08/CCAPP-Annual-Report-2024-20…

190. Pharmacy Examining Board of Canada. Pharmacy Examining Board of Canada [Internet]. Canada; [cited 2026 May 28]. Pharmacist Qualifying Examination – General Information. Available from: https://pebc.ca/pharmacists/qualifying-examination/general-information/

191. Tan X, Liu X, Shao H. Healthy China 2030: A Vision for Health Care. Value Health Reg Issues. 2017 May;12:112–4. doi:10.1016/j.vhri.2017.04.001

192. National Health Commission of the People’s Republic of China. National Health Commission of the People’s Republic of China [Internet]. China; 2018 [cited 2026 May 28]. What we do. Available from: https://en.nhc.gov.cn/2018-09/22/c_74499.htm

193. Opinions of the National Health Commission and the State Administration of Traditional Chinese Medicine on Accelerating the High-Quality Development of Pharmaceutical Services (State Council Gazette No. 10, 2019) _ China Government Website [Internet]. [cited 2026 May 28]. Available from: https://www.gov.cn/gongbao/content/2019/content_5380378.htm

194. 浙江省执业药师协会. 浙江药师 2023年第1期 - Zhejiang Pharmacist, 2023 Issue 1 [Internet]. 2023 Feb 28;(1). Available from: https://www.zjda.com/userfiles/journal/pdf/%E6%B5%99%E6%B1%9F%E8%8D%AF%…

195. National Healthcare Security Administration. 零售药店医疗保障定点管理暂行办法 - Interim Measures for the Designated Management of Retail Pharmacies for Healthcare Security [Internet]. Beijing, China: National Healthcare Security Administration; 2021 Feb. Report Order No. 3 / 国家医疗保障局令第3号. Available from: https://www.nhsa.gov.cn/attach/0/a0429e0aaab14bd5a447419d79e7ddff.pdf

196. National Medical Products Administration. National Medical Products Administration [Internet]. China; 2019 [cited 2026 May 28]. Main Responsibilities of the National Medical Products Administration. Available from: https://english.nmpa.gov.cn/2019-07/18/c_377587.htm

197. Drug Administration Law of the People’s Republic of China [Internet]. [cited 2026 May 28]. Available from: https://english.nmpa.gov.cn/2019-09/26/c_773012_2.htm

198. Xinhua News Agency. China unveils first-ever policy to boost high-quality development of pharmaceutical retail sector [Internet]. 2026 Jan 22. Available from: https://english.www.gov.cn/news/202601/22/content_WS6972298cc6d00ca5f9a…

199. Birk HO, Vrangbæk K, Rudkjøbing A. Denmark: Health System Summary, 2024 [Internet]. Copenhagen: WHO Regional Office for Europe, on behalf of the European Observatory on Health Systems and Policies; 2024. Available from: https://healthcaredenmark.dk/media/o0kphpic/dk-health-system-summary.pdf

200. Denmark: Country Health Profile 2025 [Internet]. Paris / Brussels: OECD Publishing / European Observatory on Health Systems and Policies; 2025. (State of Health in the EU). Available from: https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/12/c…

201. Danish Medicines Agency (Lægemiddelstyrelsen). Danish Medicines Agency Annual OMCL Report 2024 [Internet]. Copenhagen, Denmark: Danish Medicines Agency (Lægemiddelstyrelsen); 2025. Available from: https://laegemiddelstyrelsen.dk/~/media/22C40241448148DC8378EC7DEA2D596…

202. Danish Medicines Agency [Internet]. [cited 2026 May 28]. Pharmacy licences. Available from: https://laegemiddelstyrelsen.dk/en/pharmacies/pharmacies/pharmacy-licen…

203. Danish Medicines Agency [Internet]. [cited 2026 May 20]. Reimbursement and prices. Available from: https://laegemiddelstyrelsen.dk/en/reimbursement/

204. Ny aftale styrker apotekernes rolle i det nære sundhedsvæsen [Internet]. [cited 2026 May 26]. Available from: https://www.ism.dk/nyheder/2025/januar/ny-aftale-styrker-apotekernes-ro…

205. Fælles Medicinkort [Internet]. [cited 2026 May 28]. Available from: https://sundhedsdatastyrelsen.dk/digitale-loesninger/faelles-medicinkort

206. Data Protection Policy [Internet]. [cited 2026 May 28]. Available from: https://english.sundhedsdatastyrelsen.dk/contact/data-protection-policy

207. Hansen RN, Nørgaard LS, Rossing CV. Danish community pharmacies supporting self-care for patients. Explor Res Clin Soc Pharm. 2023 Dec;12:100343. doi:10.1016/j.rcsop.2023.100343

208. Pharmakon.dk [Internet]. [cited 2026 May 22]. Om Pharmakon. Available from: https://www.pharmakon.dk/om-pharmakon/

209. Sundhedsstrukturkommissionen. Report of the health structure commission / Sundhedsstrukturkommissionens baggrundsrapport [Internet]. København: Indenrigs- og Sundhedsministeriet; 2024. Available from: https://www.ism.dk/Media/638536236116325595/Baggrundsrapport%20-%20Sund…

210. Vogler S. PPRI Pharma Brief: Germany 2025 [Internet]. Vienna; 2025 Aug. (Pharmaceutical Pricing and Reimbursement Information (PPRI) Pharma Briefs Series). Available from: https://ppri.goeg.at/system/files/inline-files/PPRI_Pharma_Brief_DE_202…

211. Aktionsplan 2026–2029 des Bundesministeriums für Gesundheit zur Verbesserung der Arzneimitteltherapiesicherheit in Deutschland: Aktionsplan AMTS 2026–2029 [Internet]. Bonn, Germany: Bundesministerium für Gesundheit; 2026 Apr. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloa…

212. Bundesministerium für Gesundheit. Bundesministerium für Gesundheit [Internet]. [cited 2026 May 28]. Apothekenbetriebsordnung. Available from: https://www.bundesgesundheitsministerium.de/service/begriffe-von-a-z/a/…

213. Bundesministerium für Gesundheit. Bundesministerium für Gesundheit [Internet]. [cited 2026 May 28]. Warken: Wir stärken die Apotheken vor Ort – jetzt und für die Zukunft. Available from: https://www.bundesgesundheitsministerium.de/ministerium/meldungen/apoth…

214. Bundesministerium für Gesundheit. Bundesministerium für Gesundheit [Internet]. [cited 2026 May 22]. Spitzenverband Bund der Krankenkassen. Available from: https://www.bundesgesundheitsministerium.de/themen/gesundheitswesen/sel…

215. Eickhoff C, Griese-Mammen N, Mueller U, Said A, Schulz M. Primary healthcare policy and vision for community pharmacy and pharmacists in Germany. Pharm Pract. 2021 Jan 20;19(1):2248. doi:10.18549/PharmPract.2021.1.2248

216. Deutscher Apothekerverband (DAV) | ABDA [Internet]. [cited 2026 May 28]. Available from: https://www.abda.de/ueber-uns/dav/

217. ABDA. Stellungnahme der ABDA zum ApoVWG und zur 2. ApBetrO-AMPreisV-ÄndV [Internet]. Berlin: ABDA; 2025 Nov. Available from: https://www.abda.de/fileadmin/user_upload/assets/Stellungnahmen/2026/20…

218. Wir über uns [Internet]. [cited 2026 May 28]. Available from: https://www.lak-bw.de/kammer/wir-ueber-uns

219. Ministry of Social Affairs and Health [Internet]. [cited 2026 May 28]. Pharmacotherapy. Available from: https://stm.fi/en/pharmacotherapy

220. Fimea [Internet]. [cited 2026 Apr 7]. Lääkkeiden ja lääkinnällisten tuotteiden saatavuuden edistäminen. Available from: https://fimea.fi/fimean-vastuullisuus-ja-vuosiraportti-2025/laakkeiden-…

221. Fimea [Internet]. [cited 2026 May 28]. Pharmacies. Available from: https://fimea.fi/en/pharmacies

222. Finnish Medicines Agency (Fimea), Social Insurance Institution of Finland (Kela). Finnish Statistics on Medicines 2023 [Internet]. Finnish Medicines Agency (Fimea) & Kela; 2024. Available from: https://www.julkari.fi/server/api/core/bitstreams/409eeb03-2971-4e1c-ba…

223. Ministry of Social Affairs and Health [Internet]. [cited 2026 May 28]. Wellbeing services counties. Available from: https://stm.fi/en/wellbeing-services-counties

224. Mäkinen E, Koskenkorva T, Holmström AR, Airaksinen M, Kuusisto M, Kyllönen H, et al. Promoting outpatient medication safety in Finland: A mid-term review of a national medication safety programme for community pharmacies (2021–2026). Health Policy. 2025 May;155:105285. doi:10.1016/j.healthpol.2025.105285

225. Association of Finnish Pharmacies. The Association of Finnish Pharmacies: Annual Review 2021 [Internet]. Helsinki: Association of Finnish Pharmacies; 2022. Available from: https://www.apteekkariliitto.fi/wp-content/uploads/2024/06/annual-revie…

226. Suomen Farmasialiitto. Farmasialiitto [Internet]. Finland: Suomen Farmasialiitto ry; [cited 2026 May 28]. Organisaatio. Available from: https://www.farmasialiitto.fi/meista/organisaatio/

227. Gall OL, Magnien M, Jaouen V, Vincent B. La régulation du réseau des pharmacies d’officine [Internet]. Paris, France: Inspection Générale des Affaires Sociales (IGAS) & Inspection Générale des Finances (IGF); 2016. Available from: https://igas.gouv.fr/sites/igas/files/files-spip/pdf/Rapport_IGAS-IGF-_…

228. Artikel L5125-1-1 A - Wetboek volksgezondheid - Wetgeving [Internet]. [cited 2026 May 28]. Available from: https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000053279534

229. Vogler S. PPRI Pharma Brief: France 2020 [Internet]. Vienna: Gesundheit Österreich GmbH / Austrian National Public Health Institute; 2020 Oct. (Pharmaceutical Pricing and Reimbursement Information (PPRI) Pharma Briefs Series). Available from: https://jasmin.goeg.at/id/eprint/1686/1/PPRI_Pharma_Brief_FR_2020_final…

230. Union nationale des organismes d’assurance maladie complémentaire. Unocam [Internet]. [cited 2026 May 28]. Compétences et missions. Available from: https://unocam.fr/association/competences-et-missions/

231. Späth HM. Les nouvelles missions des pharmaciens d’officine et leurs rémunérations [Conference presentation] [Internet]. Conference presentation presented at. 2022 Mar 11; Reims, France. Available from: https://hal.science/hal-04760193v1/file/R%C3%A9mun%C3%A9rations%20des%2…

232. Fédération des Syndicats Pharmaceutiques de France. Fédération des Pharmaciens de France [Internet]. [cited 2026 May 28]. Qui sommes-nous ? Available from: https://www.fspf.fr/qui-sommes-nous/

233. Agence du Numérique en Santé [Internet]. 2026 [cited 2026 May 28]. Le Ségur du numérique en santé pour l’officine. Available from: https://esante.gouv.fr/segur/officine

234. 厚生労働省 [Internet]. [cited 2026 May 28]. 中央社会保険医療協議会(中央社会保険医療協 議会総会). Available from: https://www.mhlw.go.jp/stf/shingi/shingi-chuo_128154.html

235. Japan Health Policy NOW – 3.1 Japan’s Health Insurance System [Internet]. [cited 2026 May 28]. Available from: https://japanhpn.org/en/section-3-1/

236. Declareren en betalen van medische kosten, enz. | Fonds voor betaling van medische kosten via de sociale verzekering [Internet]. [cited 2026 May 28]. Available from: https://www.ssk.or.jp/seikyushiharai/index.html

237. Japan Pharmaceutical Association (JPA). Annual Report of JPA 2020–2021 [Internet]. Tokyo: Japan Pharmaceutical Association; 2021. Available from: https://www.nichiyaku.or.jp/files/co/pdf/anuual_report2020e.pdf

238. Regulation for Enforcement of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices - English - Japanese Law Translation [Internet]. [cited 2026 May 27]. Available from: https://www.japaneselawtranslation.go.jp/en/laws/view/3215/en

239. Ministry of Health, Labour and Welfare. Ministry of Health, Labour and Welfare [Internet]. 2021 [cited 2026 May 24]. 地域連携薬局及び専門医療機関連携薬局の認定基準に関するQ＆Aに ついて（令和5年3月31日一部改正）. Available from: https://www.mhlw.go.jp/web/t_doc?dataId=00tc5634&dataType=1&pageNo=1&

240. Digital Agency. E-Prescription Adoption Dashboard｜Digital Agency [Internet]. 2026 [cited 2026 May 28]. Available from: https://www.digital.go.jp/en/resources/govdashboard/electronic-prescrip…

241. Ministerie van Volksgezondheid, Welzijn en Sport (VWS). Integraal Zorgakkoord: Samen werken aan gezonde zorg [Internet]. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport; 2022 Sep. Available from: https://www.rijksoverheid.nl/site/binaries/site-content/collections/doc…

242. Ministerie van Volksgezondheid, Welzijn en Sport. De vergoeding van geneesmiddelen nu en in de toekomst [Government document] [Internet]. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport; 2025 Feb. Available from: https://open.overheid.nl/documenten/33f349b6-4b78-4a91-a4bd-6f0bf7eb888….

243. Nederlandse Zorgautoriteit. Prestatiebeschrijvingbeschikking facultatieve prestatie farmaceutische zorg TB/REG-22639-01 [Internet]. Utrecht: Nederlandse Zorgautoriteit; 2021 Dec. Available from: https://puc.overheid.nl/nza/doc/PUC_692439_22/

244. Zorginstituut Nederland. De kosten voor farmaceutische zorg [webcontent] [Internet]. Zorginstituut Nederland; [cited 2026 May 5]. Available from: https://www.farmacotherapeutischkompas.nl/algemeen/kosten

245. Medicijntekorten. Zorgverzekeraars Nederland [Internet]. 2025 Sep 30 [cited 2026 May 28]. Available from: https://www.zn.nl/dossier/medicijntekorten/

246. Centraal College Specialismen Farmacie / Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). Jaarplan 2025: Centraal College Specialismen Farmacie [Internet]. Den Haag: KNMP; 2024 Dec. Available from: https://www.knmp.nl/sites/default/files/2025-01/jaarplan_cc_2025.pdf

247. Kempen TGH, Gemmeke M, Bijlsma EY, Egberts TCG, Philbert D, Bouvy ML. Integration of pharmacy practice research in the Dutch pharmacy education continuum. Int J Pharm Pract. 2026 Apr 20;riag053. doi:10.1093/ijpp/riag053

248. Inspectie Gezondheidszorg en Jeugd (IGJ). Werkplan 2026 [Internet]. Utrecht: Inspectie Gezondheidszorg en Jeugd, Ministerie van Volksgezondheid, Welzijn en Sport; 2025. Available from: https://www.igj.nl/documenten/2025/12/11/igj-werkplan-2026

249. Schutjens MH. Juridische betekenis van professionele standaarden voor farmaceutische zorg [Internet]. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP); 2024 Feb. Available from: https://www.knmp.nl/sites/default/files/2022-01/Juridische%20kader%20ri…

250. Medicatieoverdracht voor veilige medicatiegegevens | Nictiz [Internet]. [cited 2026 May 28]. Available from: https://www.nictiz.nl/programmas/medicatieoverdracht/

251. Medicatieoverdracht | VZVZ [Internet]. [cited 2026 May 28]. Available from: https://www.vzvz.nl/initiatieven/medicatieoverdracht

252. Hoe werkt het Landelijk Schakelpunt? | AORTA-LSP [Internet]. [cited 2026 May 28]. Available from: https://www.aorta-lsp.nl/over-aorta-lsp/hoe-werkt-het-landelijk-schakel…

253. Department of Health and Social Care. GOV.UK [Internet]. [cited 2026 Feb 18]. Community Pharmacy Contractual Framework: 2024 to 2025 and 2025 to 2026. Available from: https://www.gov.uk/government/publications/community-pharmacy-contractu…

254. England NHS. NHS England » Pharmacy First [Internet]. [cited 2026 May 28]. Available from: https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-services/phar…

255. About us. Community Pharmacy England [Internet]. [cited 2026 May 28]. Available from: https://cpe.org.uk/our-work/about-us/

256. NHS Business Services Authority. Drug Tariff | NHSBSA [Internet]. [cited 2026 May 28]. Available from: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contrac…

257. NHS Business Services Authority. MYS – Pharmacy | NHSBSA [Internet]. [cited 2026 May 28]. Available from: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contrac…

258. NHS England. NHS England » Pharmacy Manual [Internet]. [cited 2026 May 28]. Available from: https://www.england.nhs.uk/long-read/pharmacy-manual/

259. Locally commissioned services. Community Pharmacy England [Internet]. [cited 2026 May 28]. Available from: https://cpe.org.uk/lpcs-and-local/locally-commissioned-services/

260. Royal College of Pharmacy. Royal College of Pharmacy [Internet]. [cited 2026 May 28]. About the College. Available from: https://www.rcpharm.org/about-the-college/

261. Royal College of Pharmacy [Internet]. [cited 2026 May 28]. Professional standards Archive. Available from: https://www.rcpharm.org/professional-standards/

262. NHS England Digital [Internet]. [cited 2026 May 28]. Electronic Prescription Service. Available from: https://digital.nhs.uk/services/electronic-prescription-service

263. NHS England Digital [Internet]. [cited 2026 May 28]. GP Connect: Update Record. Available from: https://digital.nhs.uk/services/gp-connect/gp-connect-in-your-organisat…

264. Medicaid and CHIP Payment and Access Commission (MACPAC). Medicaid Payment for Outpatient Prescription Drugs [Internet]. Washington, DC: MACPAC; 2018. Available from: https://www.macpac.gov/wp-content/uploads/2015/09/Medicaid-Payment-for-…

265. Centers for Medicare and Medicaid Services (CMS) | USAGov [Internet]. [cited 2026 May 28]. Available from: https://www.usa.gov/agencies/centers-for-medicare-and-medicaid-services

266. Duran V. Contract Year 2026 Part D Medication Therapy Management Program Guidance and Submission Instructions [Internet]. Baltimore, MD: Centers for Medicare & Medicaid Services; 2025 May. Available from: https://www.cms.gov/files/document/memo-contract-year-2026-medication-t…

267. Prescription Drugs | Medicaid [Internet]. [cited 2026 May 28]. Available from: https://www.medicaid.gov/medicaid/prescription-drugs

268. Medicaid Covered Outpatient Prescription Drug Reimbursement Information by State | Medicaid [Internet]. [cited 2026 May 24]. Available from: https://www.medicaid.gov/medicaid/prescription-drugs/state-prescription…

269. National Association of Boards of Pharmacy. Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy [Internet]. Mount Prospect, IL; 2025. Available from: https://nabp.pharmacy/members/board-resources/model-pharmacy-act-rules/

270. TSBP Website - Texas State Board of Pharmacy [Internet]. [cited 2026 May 28]. Available from: https://www.pharmacy.texas.gov/

271. U.S. Federal Trade Commission. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies [Internet]. Washington, DC: Federal Trade Commission, Office of Policy Planning; 2024. Available from: https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-…

272. American Pharmacists Association. American Pharmacists Association [Internet]. [cited 2026 May 28]. About APhA. Available from: https://www.pharmacist.com/who-we-are/

273. National Community Pharmacists Association (NCPA). 2024 NCPA Digest [Internet]. Alexandria, VA, USA: National Community Pharmacists Association; 2024 Jun. (NCPA Digest). Available from: https://www.ncpa.co/pdf/digest/2024/digest-2024.pdf

274. About CPESN USA | CPESN [Internet]. [cited 2026 May 28]. Available from: https://cpesn.com/about-cpesn-usa

275. CPESN USA. CPESN Pharmacies: Local Roots, Local Relationships, and Local Engagement – Evidence [Internet]. 2025 Aug. Available from: https://cpesn.com/sites/default/files/2026-03/EngageRx%20Evidence%20081…

276. Measure Implementation. PQA [Internet]. [cited 2026 May 28]. Available from: https://www.pqa.org/measures/measure-implementation/

277. Accreditation Council for Pharmacy Education [Internet]. [cited 2026 May 28]. Home. Available from: https://www.acpe-accredit.org/

278. Scottish Government. Primary care services [Internet]. Edinburgh: Scottish Government; [cited 2026 May 16]. Pharmacy. Available from: https://www.gov.scot/policies/primary-care-services/pharmacy/

279. Community Pharmacy Scotland [Internet]. [cited 2026 May 24]. Remuneration Arrangements 2025 / 2026. Available from: https://www.cps.scot/latest-news/pcap202518

280. Community Pharmacy Scotland (CPS). Community Pharmacy Scotland [Internet]. Edinburgh, Scotland: Community Pharmacy Scotland. Financial Framework 2025–26. Available from: https://www.cps.scot/contractor-only-financial-framework-24

281. Scottish Government, Chief Medical Officer Directorate, Pharmacy and Medicines Division. Pharmaceutical Services: Amendments in Respect of Community Pharmacy Remuneration Arrangements from 1 April 2025 [Internet]. Edinburgh; 2025 Jul. Report NHS Circular PCA (P) (2025) 18. Available from: https://www.publications.scot.nhs.uk/files/pca2025-p-18.pdf

282. National Services Scotland [Internet]. [cited 2026 May 28]. Practitioner Services. Available from: https://www.nss.nhs.scot/departments/practitioner-services/

283. Campbell I, Harrison H, Kurdi A. A qualitative study exploring the challenges and enablers of pharmacists with a recent background in community pharmacy transitioning into primary care. Int J Clin Pharm. 2024 Jun;46(3):704–13. doi:10.1007/s11096-024-01710-4

284. Pharmacy | NHS Education for Scotland [Internet]. [cited 2026 May 28]. Available from: https://www.nes.scot.nhs.uk/our-work/pharmacy/

285. Scottish Patient Safety Programme (SPSP) – Healthcare Improvement Scotland [Internet]. [cited 2026 May 28]. Available from: https://www.healthcareimprovementscotland.scot/improving-care/improveme…

286. Community Pharmacy Scotland [Internet]. [cited 2026 May 28]. Quality Improvement. Available from: https://www.cps.scot/quality-improvement

287. Public Health Scotland. Community Pharmacy Contractor Activity: Data for October to December 2025 [Internet]. Edinburgh, Scotland: Public Health Scotland; 2026 Mar. (Official Statistics). Available from: https://publichealthscotland.scot/media/37655/2026-03-10-community-phar…

288. Community Pharmacy – Contractor Activity - Open data - Prescribing data - System monitoring, accountability and quality of care - Healthcare system - Public Health Scotland [Internet]. [cited 2026 Mar 8]. Available from: https://publichealthscotland.scot/healthcare-system/system-monitoring-a…

289. National Services Scotland [Internet]. [cited 2026 May 28]. About the Digital Prescribing and Dispensing Pathways programme. Available from: https://www.nss.nhs.scot/national-programmes/digital-prescribing-and-di…

290. Pharmacy 2030 Vision [Internet]. [cited 2026 Mar 23]. Available from: https://www.rpharms.com/pharmacy2030

291. Viegas R, Poe M, Pinto GS. Community Pharmacy at a Glance 2021: Regulation, Scope of Practice, Remuneration, and Distribution of Medicines Through Community Pharmacy Premises and Other Outlets [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation (FIP); 2021. Available from: https://farmaciavirtuale.it/wp-content/uploads/2021/07/Community-pharma…

292. van Tuyl L, Vis E, Bosmans M, Friele R, Batenburg R. Visies op taakherschikking: Een inventariserend onderzoek naar de diversiteit, kansen en belemmeringen van taakherschikking in Nederland [Internet]. Utrecht: Nivel; 2020. Available from: https://www.nivel.nl/sites/default/files/bestanden/1003844.pdf

293. Kokko M, Hyvärinen A, Reinikainen L. Apteekkien tilinpäätösanalyysi vuosilta 2020–2023 [Internet]. Kuopio: Lääkealan turvallisuus- ja kehittämiskeskus Fimea; 2025. (Fimea kehittää, arvioi ja informoi). Available from: https://www.julkari.fi/server/api/core/bitstreams/2451a19f-aa04-40cd-96…

294. Robberechts A. Implementation of type 3 medication review in Flanders : obstacles and opportunities [Internet]. University of Antwerp; 2024 [cited 2026 May 30]. Available from: https://hdl.handle.net/10067/2052640151162165141 doi:10.63028/10067/2052640151162165141

295. Urick BY, Pathak S, Hughes TD, Ferreri SP. Design and effect of performance-based pharmacy payment models. J Manag Care Spec Pharm. 2021 Mar;27(3):306–15. doi:10.18553/jmcp.2021.27.3.306

296. Nihon Chouzai Co., Ltd. Nihon Chouzai Integrated Report 2021 [Integrated Report / Annual Integrated Report] [Internet]. Tokyo, Japan: Nihon Chouzai Co., Ltd.; 2021. Available from: https://www.nicho.co.jp/en/ir/library/annual/main/09/teaserItems1/02/li…

297. Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA. Remunerated patient care services and injections by pharmacists: An international update. Can Pharm J Rev Pharm Can. 2019;152(2). doi:10.1177/1715163518811065 PubMed Central PMCID: PMC6410431.

298. Tong V, Krass I, Aslani P. An in-depth examination of funded and unfunded cognitive pharmaceutical services. Explor Res Clin Soc Pharm. 2021 Sep;3:100060. doi:10.1016/j.rcsop.2021.100060

299. Australian Government Department of Health. First report on key performance measures for the Seventh Community Pharmacy Agreement (7CPA) [Government Report] [Internet]. Canberra, ACT, Australia: Australian Government Department of Health; 2022. Available from: https://www.health.gov.au/sites/default/files/2022-12/first-report-on-k…

300. Cormack M. Unleashing the potential of our health workforce Scope of Practice Review Final Report [Internet]. Canberra, ACT: Australian Government Department of Health and Aged Care; 2024. Available from: https://www.health.gov.au/sites/default/files/2024-11/unleashing-the-po…

301. Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Effective Practice and Organisation of Care Group, editor. Cochrane Database Syst Rev. 2016 Nov 22;2017(10). doi:10.1002/14651858.CD011227.pub2

302. KPMG. Pharmacist Scope of Practice Review: Final Report [Government commissioned report] [Internet]. Hobart, Tasmania, Australia: Department of Health Tasmania; 2023. Available from: https://www.health.tas.gov.au/sites/default/files/2023-09/pharmacist_sc…

303. Seda V, Carter SR, Moles RJ, Schneider CR. Implementation priorities in Australian community pharmacy: A semi-structured survey of Australian pharmacists. Explor Res Clin Soc Pharm. 2026 Mar;21:100683. doi:10.1016/j.rcsop.2025.100683

304. Australian Government Department of Health and Aged Care. Eighth Community Pharmacy Agreement [Government Agreement / Policy Agreement] [Internet]. Canberra, ACT, Australia: Pharmacy Guild of Australia; 2024 Jun. Available from: https://www.health.gov.au/sites/default/files/2024-06/eighth-community-…

305. Implementing My Health Record in your healthcare organisation [Internet]. [cited 2026 Mar 8]. Available from: https://www.digitalhealth.gov.au/healthcare-providers/initiatives-and-p…

306. Smith D, Couzos S, Tremlett M, Loller H. Integrating Pharmacists within Aboriginal Community Controlled Health Services to improve Chronic Disease Management (IPAC) Project: Executive Summary, Final Report – Part A [Internet]. Canberra, ACT, Australia: Australian Government Department of Health; 2020. Available from: https://www.health.gov.au/sites/default/files/2023-06/integrating-pract…

307. Australian Government Department of Health and Aged Care. National Medicines Policy 2022 [Internet]. Canberra, ACT: Australian Government Department of Health and Aged Care; 2022. Available from: https://www.health.gov.au/sites/default/files/2022-12/national-medicine…

308. Shahin W, Dunkley K, Wang K, Hussain Z, Thrimawithana T. Australian community pharmacists’ views and preparedness to provide a UTI management service. Int J Pharm Pract. 2025 Dec 31;riaf127. doi:10.1093/ijpp/riaf127

309. Yong FR, Hor SY, Bajorek BV. Australian community pharmacy service provision factors, stresses and strains: A qualitative study. Explor Res Clin Soc Pharm. 2023 Mar;9:100247. doi:10.1016/j.rcsop.2023.100247

310. Australian Government Department of Health and Aged Care. Community Pharmacy Agreements: Rural Support and Aboriginal and Torres Strait Islander Pharmacy Programs – Program Data Report [Program data report / Statistical report] [Internet]. Canberra, ACT, Australia: Australian Government Department of Health and Aged Care; 2024. Available from: https://www.health.gov.au/sites/default/files/2024-08/community-pharmac…

311. Regional Pharmacy Maintenance Allowance - Pharmacy Programs Administrator. AHA [Internet]. [cited 2026 May 1]. Available from: https://www.ppaonline.com.au/programs/rural-support-programs/regional-p…

312. Australian Government Department of Health and Aged Care. Community Pharmacy Programs under the Eighth Community Pharmacy Agreement [Internet]. Canberra, ACT: Australian Government Department of Health and Aged Care; 2024 Jun. Available from: https://www.health.gov.au/sites/default/files/2024-06/community-pharmac…

313. Opioid Dependence Treatment (ODT) Community Pharmacy Program - Pharmacy Programs Administrator. AHA [Internet]. [cited 2026 Jun 1]. Available from: https://www.ppaonline.com.au/programs/medication-adherence-programs-2/o…

314. Raiche T, Pammett R, Dattani S, Dolovich L, Hamilton K, Kennie-Kaulbach N, et al. Community pharmacists’ evolving role in Canadian primary health care: a vision of harmonization in a patchwork system. Pharm Pract. 2020 Oct 18;18(4):2171. doi:10.18549/PharmPract.2020.4.2171

315. Tadrous M, Liu S, Tsuyuki RT. Why pharmacy practice needs quality indicators. Can Pharm J Rev Pharm Can. 2025;158(6). doi:10.1177/17151635251384474

316. Schindel TJ, Breault RR, Hughes CA. “It Made a Difference to Me”: A Comparative Case Study of Community Pharmacists’ Care Planning Services in Primary Health Care. Pharmacy. 2019 Jul 11;7(3):90. doi:10.3390/pharmacy7030090

317. Kim JJ, Tian AH, Pham L, Nakhla N, Houle SKD, Wong WWL, et al. Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis. Int J Pharm Pract. 2021 May 25;29(3):228–34. doi:10.1093/ijpp/riab006

318. Rafferty E, Yaghoubi M, Taylor J, Farag M. Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan. Cost Eff Resour Alloc. 2017 Dec;15(1):3. doi:10.1186/s12962-017-0066-7

319. Hamarneh YNA, Ramrattan DA, Tsuyuki RT, Sullivan KW, Pan B, Simpson SH. What services do people seek when they visit a community pharmacy care clinic? Can Pharm J Rev Pharm Can. 2026;159(1). doi:10.3138/cpj-25-0029

320. Grootendorst P. Pharmacy location and medical need: regional evidence from Canada. BMC Health Serv Res. 2022 Nov 3;22(1):1309. doi:10.1186/s12913-022-08709-5

321. National Association of Pharmacy Regulatory Authorities (NAPRA). Model Standards of Practice for Pharmacists and Pharmacy Technicians in Canada [Professional Practice Standards] [Internet]. Ottawa, ON, Canada: National Association of Pharmacy Regulatory Authorities; 2022. Available from: https://www.napra.ca/wp-content/uploads/2022/09/NAPRA-MSOP-Feb-2022-EN-…

322. Winslade N, Taylor L, Shi S, Schuwirth L, Van Der Vleuten C, Tamblyn R. Monitoring Community Pharmacist’s Quality of Care: A feasibility study of using pharmacy claims data to assess performance. BMC Health Serv Res. 2011 Dec;11(1):12. doi:10.1186/1472-6963-11-12

323. Winslade N, Tamblyn R. Determinants of community pharmacists’ quality of care: a population-based cohort study using pharmacy administrative claims data. BMJ Open. 2017 Sep;7(9):e015877. doi:10.1136/bmjopen-2017-015877

324. Minard LV, Deal H, Harrison ME, Toombs K, Neville H, Meade A. Pharmacists’ Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators. Chamberlain AM, editor. PLOS ONE. 2016 Apr 4;11(4):e0152903. doi:10.1371/journal.pone.0152903

325. Isenor JE, Cossette B, Murphy AL, Breton M, Mathews M, Moritz LR, et al. Community pharmacists’ expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study. Int J Clin Pharm. 2023 Feb;45(1):64–78. doi:10.1007/s11096-022-01430-7

326. Bill C-64: An Act respecting pharmacare [Internet]. C–64. 2024 Feb 29. Available from: https://www.parl.ca/Content/Bills/441/Government/C-64/C-64_1/C-64_1.PDF

327. British Columbia Ministry of Health. Pharmaceutical Care Management Strategy [Internet]. Victoria, British Columbia, Canada: Ministry of Health; 2020 Jul. Available from: https://www2.gov.bc.ca/gov/content/health/practitioner-professional-res…

328. Leung V, Tharmalingam S, Cooper J, Charlebois M. Canadian community pharmacists’ use of digital health technologies in practice. Can Pharm J Rev Pharm Can. 2016 Jan;149(1):38–45. doi:10.1177/1715163515618679

329. Etezad S, Fleming M, Weigand HA, Hartt CM, Dutton DJ, Barker JR, et al. Exploring the well-being of community pharmacy professionals, turnover intention and patient safety: Time to include operational responsibility. Can Pharm J Rev Pharm Can. 2023 Mar;156(2):71–84. doi:10.1177/17151635231152170

330. Wheeler G, Froese T. Community Pharmacist Collaboration with Family Physicians in Primary Care Clinics [White Paper] [Internet]. British Columbia, Canada: City Centre Pharmacy / Oliver Pharmacy / Rose Valley Pharmacy; 2021. Available from: https://www.bcpharmacy.ca/system/files/assets/paragraphs/file/file/Whit…

331. Pechlivanoglou P, Abrahamyan L, MacKeigan L, Consiglio GP, Dolovich L, Li P, et al. Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario. BMC Health Serv Res. 2016 Dec;16(1):666. doi:10.1186/s12913-016-1888-2

332. Wang L, Ramroop S. Geographic disparities in accessing community pharmacies among vulnerable populations in the Greater Toronto Area. Can J Public Health. 2018 Dec;109(5– 6):821–32. doi:10.17269/s41997-018-0110-1

333. Canada G of CIS. Non-Insured Health Benefits program for First Nations and Inuit: Pharmacy benefits [resource list] [Internet]. 2019 [cited 2026 May 23]. Available from: https://www.sac-isc.gc.ca/eng/1574784515492/1574784549876

334. Cossette B, Ricard G, Poirier R, Gosselin S, Langlois M, Imbeault P, et al. Pharmacist‐led transitions of care between hospitals, primary care clinics, and community pharmacies. J Am Geriatr Soc. 2022 Mar;70(3):766–76. doi:10.1111/jgs.17575

335. Zhang T, Lambert H, Zhao L, Liu R, Shen X, Wang D, et al. Antibiotic Stewardship in Retail Pharmacies and the Access-Excess Challenge in China: A Policy Review. Antibiotics. 2022 Jan 21;11(2):141. doi:10.3390/antibiotics11020141

336. Zhu X, Hu H, Yao D. Exploring community pharmacy manager/ pharmacist perceptions and responses to China’s dual-channel policy for improving access and rational use of innovative drugs: a qualitative study. Int J Clin Pharm. 2025 Dec;47(6):1784–93. doi:10.1007/s11096-025-01957-5

337. General Office of the State Council of the People’s Republic of China. Notice on issuing the 14th Five-Year Plan for Universal Medical Security / 国务院办公厅关于印发“十四五”全民医疗保障 规划的通知 [Internet]. Beijing, China: State Council of the People’s Republic of China; 2021. Available from: https://www.nhsa.gov.cn/art/2021/9/29/art_37_6137.html

338. Xi X, Huang Y, Lu Q, Ung COL, Hu H. Community pharmacists’ opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China. Int J Clin Pharm. 2019 Apr;41(2):478–87. doi:10.1007/s11096-019-00802-w

339. Sun Q, Wang Y, Wang P, Huang Y, Xi X. Residents Preferences for Pharmacist-Managed Clinic in China: A Discrete Choice Experiment. Patient Prefer Adherence. 2024 Jul;Volume 18:1409–22. doi:10.2147/PPA.S457655

340. Zhang X, Tang Z, Zhang Y, Tong WK, Xia Q, Han B, et al. Knowledge, attitudes, and practices of primary healthcare practitioners regarding pharmacist clinics: a cross-sectional study in Shanghai. BMC Health Serv Res. 2024 May 29;24(1):677. doi:10.1186/s12913-024-11136-3

341. Yao H, Li C, Shi X, Peng B, Kang Z, Sun J, et al. Quality evaluation of online platforms information for retail of prescription medicines in China: an observational study of the case of paroxetine. BMC Med Inform Decis Mak. 2026 Feb 21;26(1):93. doi:10.1186/s12911-026-03386-4

342. Zhang X, Tang Z, Zhang Y, Tong WK, Xia Q, Han B, et al. Knowledge, attitudes, and practices of primary healthcare practitioners regarding pharmacist clinics: a cross-sectional study in Shanghai. BMC Health Serv Res. 2024 May 29;24(1):677. doi:10.1186/s12913-024-11136-3

343. Wu J, Niu H, Duan S, Ao B, Chen J, Chen Y, et al. Current status of pharmacists in community pharmacies in China in the health management of chronic respiratory diseases. BMC Public Health. 2025 Mar 18;25(1):1052. doi:10.1186/s12889-025-22272-8

344. Yao D, Hu Y, Harnett JE, Hu H, Ung COL. Community pharmacist’s perceptions and practice behaviors related to traditional and complementary medicines in China: A cross-sectional study. Eur J Integr Med. 2020 Dec;40:101225. doi:10.1016/j.eujim.2020.101225

345. Qu J, Zuo W, Wang S, Du L, Liu X, Gao Y, et al. Knowledge, perceptions and practices of pharmacists regarding generic substitution in China: a cross-sectional study. BMJ Open. 2021 Oct;11(10):e051277. doi:10.1136/bmjopen-2021-051277

346. State Administration for Market Regulation. 药品经营和使用质量监督管理办法 - Measures for the Supervision and Administration of the Quality of Drug Distribution and Use [Internet]. 2023 Sep 27. Available from: https://sjfg.samr.gov.cn/law/file//pdf/3238901/1697788049802.pdf

347. Shanghai Municipal Drug Administration; Shanghai Municipal Commission of Commerce; Several Opinions on Promoting the Healthy Development of Shanghai’s Retail Pharmacy Industry / 关于促进上海市药品零售行业健康发展的若干意见 [Internet]. Shanghai, China; 2024 Jun. Report 沪药监规〔2024〕3号. Available from: https://yjj.sh.gov.cn/cmsres/9a/9a6ec956d9934644ab1e17aac0d3906c/bbfc9a…

348. Bu F, Sun H, Li L, Tang F, Zhang X, Yan J, et al. Artificial intelligence-based internet hospital pharmacy services in China: Perspective based on a case study. Front Pharmacol. 2022 Nov 9;13:1027808. doi:10.3389/fphar.2022.1027808

349. Xiao P. China’s online pharmacy: its regulatory policy and a future research agenda for the emerging AI age. Med Law Rev. 2025 Jul 14;33(3):fwaf024. doi:10.1093/medlaw/fwaf024

350. Li Q, Jin Z, Liao Y, Dai H, Meng J, Li L. Exploring information technology utilization and needs in community pharmacies: a cross-sectional survey in Shanghai, China. Front Pharmacol. 2025 Feb 11;16:1554141. doi:10.3389/fphar.2025.1554141

351. Cai S, Huang X, Van C, Li W, Yan M, Lu Y, et al. General practitioners’ attitudes towards and frequency of collaboration with pharmacists in China: a cross-sectional study. BMC Health Serv Res. 2023 Oct 27;23(1):1174. doi:10.1186/s12913-023-10151-0

352. Zhao Z, Zhang S, Zheng T, Hu M. Geographical and temporal variations in availability of national price negotiated novel anticancer drugs: a spatial statistical study based on two cross-sectional datasets in China. Front Pharmacol. 2025 Jul 25;16:1604008. doi:10.3389/fphar.2025.1604008

353. National Health Commission of the People’s Republic of China. National Health Commission of the People’s Republic of China [Internet]. [cited 2026 Jun 4]. State Council’s Approval of the Implementation Plan for the ‘Strengthening the Foundation of Medical and Health Services’. Available from: https://www.nhc.gov.cn/wjw/xwdt/202509/e3a802cef89f470ead8b9557c2ac65ce…

354. Sun Y, Jia Z, Lan L, Xie X, Xie H, Ji C. Patient preferences for community pharmacy service models in diabetes care: a discrete choice experiment. Int J Clin Pharm. 2026 Mar 16. doi:10.1007/s11096-025-02080-1

355. Liu R, Cao Y, Chu A, Wu H. Current situation of pharmacy services in community health centers and the functioning of pharmacists in family doctor teams in Shanghai. Chin Gen Pract J. 2024 Apr;1(1):18–26. doi:10.1016/j.cgpj.2024.03.001

356. Deng Z, Zhou P, Lu Y, Li Z, Yao M, Li Y, et al. The integration of hospital pharmacists into primary care settings in Shenzhen, China: a qualitative study. BMC Health Serv Res. 2025 Feb 3;25(1):197. doi:10.1186/s12913-025-12351-2

357. Chen H, Ung COL, Chi P, Wu J, Tang D, Hu H. Consumers’ Perceptions About Pharmaceutical Care Provided by Community Pharmacists in China in Relation to Over-the-Counter Drugs: A Qualitative Study. Inq J Health Care Organ Provis Financ. 2018 Jan;55:0046958018793292. doi:10.1177/0046958018793292

358. Ministeriet for Sundhed og Forebyggelse. Rapport om modernisering af apotekersektoren [Internet]. København: Ministeriet for Sundhed og Forebyggelse; 2014 Jun. Available from: https://www.ism.dk/Media/637643656833137313/Rapport%20om%20moderniserin…

359. Hansen RN, Nørgaard LS, Hedegaard U, Søndergaard L, Servilieri K, Bendixen S, et al. Integration of and visions for community pharmacy in primary health care in Denmark. Pharm Pract. 2021 Jan 22;19(1):2212. doi:10.18549/PharmPract.2021.1.2212

360. Özer S, Thomsen E, Paul B. Schüder. PHIS Pharma Profile Denmark [Internet]. Vienna, Austria: Pharmaceutical Health Information System (PHIS); 2011. (PHIS Pharma Profile). Available from: http://ppri.goeg.at/sites/ppri.goeg.at/files/inline-files/V9_DK%20PHIS%…

361. MedCom. Distribution of dose-packed medicine / Udbredelse af dosispakket medicin: Håndbog til den kommunale projektleder og projektgruppe [Internet]. Odense, Denmark: MedCom; 2025. Available from: https://medcom.dk/wp-content/uploads/2025/02/Implementering-af-dosispak…

362. Larson A, Musse I, Mitrovich R, Shanmugam P, Vohra D, Lansdale AJ, et al. The effect of pharmacists as vaccinators on uptake of influenza vaccination in Denmark: An interrupted time series analysis. Res Soc Adm Pharm. 2025 Nov;21(11):897–903. doi:10.1016/j.sapharm.2025.06.100

363. Lægemiddelstyrelsen. Advantages and disadvantages of introducing generic prescriptions in Denmark / Fordele og ulemper ved indførsel af generisk ordination i Danmark [Internet]. København; 2025 Mar. Available from: https://laegemiddelstyrelsen.dk/da/udgivelser/2025/analyse-af-fordele-o…

364. Indenrigs- og Sundhedsministeriet. Forslag til Lov om ændring af lov om apoteksvirksomhed og lov om lægemidler [Legislative proposal (Lovforslag)] [Internet]. København, Danmark: Indenrigs- og Sundhedsministeriet; 2024 Feb [cited 2026 May 20]. Legislative proposal (Lovforslag) LSF 127 (2023/1). Available from: https://www.ft.dk/samling/20231/lovforslag/L127/index.htm

365. Danmarks Apotekerforening. Pharmacies in the healthcare system of the future / Apotekerne i fremtidens sundhedsvæsen [Internet]. København, Denmark: Danmarks Apotekerforening; 2021. Available from: https://www.apotekerforeningen.dk/media/5xkbs4zf/apotekerne-10-indsatse…

366. Josendal AV, Bergmo TS, Clausen SS, Hammar T, Lind KF, Manskow US, et al. Digitally shared medication lists – A scoping review. Int J Med Inf. 2026 Jul;215:106443. doi:10.1016/j.ijmedinf.2026.106443

367. Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data Resource Profile: The Danish National Prescription Registry. Int J Epidemiol. 2016 Oct 27;dyw213. doi:10.1093/ije/dyw213

368. Lech LVJ, Husted GR, Almarsdottír AB, Andersen TRH, Rossing C, Nørgaard LS. Hospital and Community Pharmacists’ Views of and Perspectives on the Establishment of an Intraprofessional Collaboration in the Transition of Care for Newly Discharged Patients. Innov Pharm. 2020 Aug 5;11(3):4. doi:10.24926/iip.v11i3.2440

369. The Danish Government. Strategy for life science towards 2030 [Internet]. Copenhagen, Denmark: Government of Denmark; 2024. Available from: https://www.em.dk/Media/638809934299361599/Strategy%20for%20life%20scie…

370. Danish Competition and Consumer Authority, Finnish Competition and Consumer. Joint Nordic Report: Online pharmacy markets in the Nordics [Internet]. Copenhagen / Helsinki / Reykjavik / Bergen / Stockholm: Joint publication of the Nordic Competition Authorities; 2021. Available from: https://www.kkv.fi/uploads/sites/2/2021/12/nordic-report-2021-online-ph…

371. Kretzschmar A. Input til Sundhedsstrukturkommissionen [Internet]. København, Denmark; 2023. Available from: https://www.ism.dk/Media/638276967541936499/Input%20fra%20Sundhed%20Dan…

372. Indenrigs- og Sundhedsministeriet, Danske Regioner; Report from the working group on pharmacy health services / Afrapportering fra arbejdsgruppen for apotekernes sundhedsydelser [Internet]. København: Indenrigs- og Sundhedsministeriet; 2023. Available from: https://www.ism.dk/Media/638236367331149695/Afrapportering%20fra%20arbe…

373. Khan U, Lega F. Health Management 2.0: Transformational Leadership for Challenging Times [Internet]. Emerald Publishing Limited; 2021 [cited 2026 Jun 2]. Available from: https://www.emerald.com/books/book/13696/Health-Management-2-0Transform… doi:10.1108/9781800433427

374. GKV-Spitzenverband, Deutscher Apothekerverband. Framework agreement on the supply of pharmaceuticals / Rahmenvertrag über die Arzneimittelversorgung nach § 129 Absatz 2 SGB V [Internet]. Berlin, Germany; 2026 Apr. Available from: https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1…

375. Ann-Christin Kroenert, Thilo Bertsche. Implementation, barriers, solving strategies and future perspectives of reimbursed community pharmacy services – a nationwide survey for community pharmacies in Germany [Internet]. Vol. 24. 2024 Nov 27;24. doi:10.1186/s12913-024-11745-y PubMed PMID: 39596592.

376. Statement of the German Medical Association on the ApoVWG / Stellungnahme zum ApoVWG [Internet]. Berlin, Germany: Bundesärztekammer; 2025 Nov. Available from: https://www.bundesaerztekammer.de/fileadmin/user_upload/BAEK/Politik/St…

377. ABDA – Bundesvereinigung Deutscher Apothekerverbände. Fact sheet on pharmacy remuneration / Faktenblatt: Apothekenhonorierung [Internet]. Berlin: ABDA – Bundesvereinigung Deutscher Apothekerverbände; 2025. Available from: https://www.abda.de/fileadmin/user_upload/assets/Faktenblaetter/Faktenb…

378. GKV-Spitzenverband. Für eine moderne und wohnortnahe Arzneimittelversorgung [Internet]. Berlin: GKV-Spitzenverband; 2024 Apr. Available from: https://www.gkv-spitzenverband.de/media/dokumente/service_1/publikation…

379. Bundesministerium für Gesundheit. Maßnahmenübersicht Reformen im Apothekenwesen [Internet]. berlin: Bundesministerium für Gesundheit; 2025 Dec. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloa…

380. Vaccinaties in apotheken | ABDA [Internet]. [cited 2026 Jun 1]. Available from: https://www.abda.de/fuer-apotheker/schutzimpfungen/schutzimpfungen-in-a…

381. Entwurf eines Gesetzes zur Weiterentwicklung der Apothekenversorgung [Internet]. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloa…

382. GmbH AMDA. Pharmazeutische Zeitung online [Internet]. [cited 2026 May 23]. Abgabeverordnung: Abgabe von Selbsttests auf Influenza nun legal. Available from: https://www.pharmazeutische-zeitung.de/abgabe-von-selbsttests-auf-influ…

383. Bundesministerium für Gesundheit. Entwurf eines Gesetzes für eine Apothekenhonorar- und Apothekenstrukturreform (Apotheken-Reformgesetz – ApoRG) [Legislative Draft] [Internet]. Berlin: Bundesministerium für Gesundheit; 2024 Jun. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloa…

384. ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V. ABDA statement on the government draft ApoVWG / Stellungnahme der ABDA zum Entwurf eines Gesetzes zur Weiterentwicklung der Apothekenversorgung (Apothekenversorgungsweiterentwicklungsgesetz – ApoVWG) (Bundestags-Drucksache 21/4084) [Internet]. Berlin, Germany: ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V.; 2026 Mar. Available from: https://www.abda.de/fileadmin/user_upload/assets/Stellungnahmen/2026/20…

385. GKV-Spitzenverband. Stellungnahme des GKV-Spitzenverbandes vom 26.02.2026 [Internet]. Berlin, Germany: GKV-Spitzenverband; 2026 Feb [cited 2026 Apr 8]. Available from: https://www.gkv-spitzenverband.de/media/dokumente/presse/p_stellungnahm…

386. Moecker R, Fuchs A, ARMIN Study Group, Eickhoff C, Mueller U, Schulz M, et al. Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study. Int J Clin Pharm. 2022 Dec;44(6):1380–93. doi:10.1007/s11096-022-01434-3

387. ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V. Apotheke 2030 – Perspektiven zur pharmazeutischen Versorgung in Deutschland 2.0 [Strategic Vision Document] [Internet]. Berlin, Germany: ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V.; 2022. Available from: https://www.abda.de/fileadmin/user_upload/assets/Apotheke_2030/Apotheke…

388. Economist Impact. Germany roadmap: Going the extra mile to narrow inclusivity gaps for rural and migrant populations [Internet]. Economist Impact; 2025. (Health Inclusivity Index). Available from: https://insights.economistenterprise.com/projects/health-inclusivity-in…

389. Seidling HM, Send AFJ, Bittmann J, Renner K, Dewald B, Lange D, et al. Medication review in German community pharmacies – Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project. Res Soc Adm Pharm. 2017 Nov;13(6):1127–34. doi:10.1016/j.sapharm.2016.10.016

390. Entwurf eines Gesetzes zur Weiterentwicklung der Apothekenversorgung.

391. Zimmermann N, Siefert J, McIntosh T, Mészáros Á. Evaluating the Perceptions, Expectations, and Concerns of Community Pharmacists in Germany Regarding Prescribing by Pharmacists. Healthcare. 2025 Sep 30;13(19):2490. doi:10.3390/healthcare13192490

392. Michel DE, Tonna AP, Dartsch DC, Weidmann AE. Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders’ recommendations for mechanisms of change using the nominal group technique. Int J Clin Pharm. 2024 Jun;46(3):714–26. doi:10.1007/s11096-024-01708-y

393. Klasing S, Dörje F, Hilgarth H, Metzger N, Richling I, Seidling HM. Continuity of medication information transfer and continuous medication supply during hospital-to-home transitions -nationwide surveys in hospital and community pharmacies after implementing new legal requirements in Germany. BMC Health Serv Res. 2024 Aug 27;24(1):993. doi:10.1186/s12913-024-11208-4

394. ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V. Stellungnahme der ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V. zu den Referentenentwürfen für ein Gesetz zur Weiterentwicklung der Apothekenversorgung [Internet]. Berlin, Germany: ABDA – Bundesvereinigung Deutscher Apothekerverbände e. V.; 2025 Nov. Available from: https://www.abda.de/fileadmin/user_upload/assets/Stellungnahmen/2026/20…

395. House of Commons Health and Social Care Committee. Pharmacy [Internet]. London: House of Commons Health and Social Care Committee; 2024 May. (Third Report of Session 2023–24). Report HC 140. Available from: https://committees.parliament.uk/publications/45156/documents/223614/de…

396. Schafheutle EI, Moss AA, Hindi AMK, Gibson J, Lovatt E, Robinson K, et al. Do pay-for-performance schemes improve quality in community pharmacy? A mixed-methods study exploring stakeholder perspectives on implementation of the nationwide Pharmacy Quality Scheme (PQS) in England? Berrou I, editor. PLOS ONE. 2025 Apr 16;20(4):e0319215. doi:10.1371/journal.pone.0319215

397. NHS England. Pharmacy Quality Scheme: Guidance 2023/24 [Internet]. London, United Kingdom: NHS England; 2023 Jun. Report no.: PRN00176. Available from: https://www.england.nhs.uk/wp-content/uploads/2021/09/PRN00176-pharmacy…

398. Willis S. Almost 80% of pharmacies ‘unsustainable’, finds NHS-commissioned economic review [Internet]. Vol. 314. 2025 Mar 31 [cited 2026 Feb 7];314(7995). Available from: https://pharmaceutical-journal.com/article/news/almost-80-of-pharmacies… doi:10.1211/PJ.2025.1.351848

399. Murray R. Community Pharmacy Clinical Services Review [Internet]. London: NHS England; 2016. Available from: https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/20…

400. Elliott RA, Tanajewski L, Gkountouras G, Avery AJ, Barber N, Mehta R, et al. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice. PharmacoEconomics. 2017 Dec;35(12):1237–55. doi:10.1007/s40273-017-0554-9

401. Thomas KA, Ismail SA, Chantler T. Do community pharmacies add value to immunization programs? A systematic review from the UK between 2015–2025 [Internet]. medRxiv; 2025. Available from: https://www.medrxiv.org/content/10.1101/2025.09.12.25335325v2.full.pdf doi:10.1101/2025.09.12.25335325

402. Community Pharmacy England. Briefing 035/23: Updated Guidance on the Hypertension Case-Finding Service [Internet]. London: Community Pharmacy England; 2023. Available from: https://cpe.org.uk/wp-content/uploads/2023/11/Briefing-035.23-Updated-g…

403. Anderson C, Sharma R. Primary health care policy and vision for community pharmacy and pharmacists in England. Pharm Pract. 2020 Mar 31;18(1):1870. doi:10.18549/PharmPract.2020.1.1870

404. Healthy Living Pharmacies. Community Pharmacy England [Internet]. [cited 2026 Jun 2]. Available from: https://cpe.org.uk/national-pharmacy-services/essential-services/health…

405. Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Res Soc Adm Pharm. 2009 Dec;5(4):305–18. doi:10.1016/j.sapharm.2009.01.003

406. Alsaeed BA, Hall J, Keers RN. Evaluating pharmacist independent prescribing for patients with mental illness in community care: a qualitative study. Front Psychiatry. 2025 Sep 8;16:1637132. doi:10.3389/fpsyt.2025.1637132

407. House of Commons Health and Social Care Committee. Pharmacy: Government Response [Internet]. London: House of Commons Health and Social Care Committee; 2025 Jan. (First Special Report of Session 2024–25). Report HC 602. Available from: https://committees.parliament.uk/publications/46179/documents/231035/de…

408. Hindi AMK, Schafheutle EI, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review. Health Expect. 2018 Apr;21(2):409–28. doi:10.1111/hex.12639

409. Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open. 2015 May;5(5):e007328. doi:10.1136/bmjopen-2014-007328

410. Christie & Co. Pharmacy Market Review 2025: An Insight into the UK Pharmacy Market [Internet]. London: Christie & Co; 2025. Available from: https://assets-eu-01.kc-usercontent.com/6bb3df3c-b648-01ae-2357-22fa5c7…

411. Clark SD, Newing A. Assessing spatial accessibility of community pharmacies in England and Wales using floating catchment area techniques. J Pharm Policy Pract. 2025 Dec 31;18(1):2466203. doi:10.1080/20523211.2025.2466203

412. NHS England. Pharmacy First: Digital Transformation of Primary Care – General Practice and Community Pharmacy [Internet]. London, United Kingdom: NHS England; 2025 Apr. Available from: https://cpe.org.uk/wp-content/uploads/2025/04/Digital-Transformation-of…

413. Garfield S, Hibberd R, Barber N. English community pharmacists’ experiences of using electronic transmission of prescriptions: a qualitative study. BMC Health Serv Res. 2013 Dec;13(1):435. doi:10.1186/1472-6963-13-435

414. NHS England. Electronic Repeat Dispensing: Guidance [Internet]. Leeds: NHS England; 2015. Available from: https://www.england.nhs.uk/digitaltechnology/wp-content/uploads/sites/3…

415. Fynn J, Lamptey M, Coote G, Nazar H, Twigg M, Newman J, et al. Community Pharmacy Integration – an evaluation of community pharmacy using an integrated clinical electronic health records system (SystmOne) [Internet]. Cambridge, United Kingdom: Health Innovation East; 2024. Available from: https://healthinnovationeast.co.uk/wp-content/uploads/2024/12/Evaluatio…

416. Community Pharmacy England. Pressures Survey 2025: Funding and Profitability Report [Survey Report] [Internet]. London: Community Pharmacy England; 2025. Available from: https://cpe.org.uk/wp-content/uploads/2025/08/Pharmacy-Pressures-Survey…

417. Royal Pharmaceutical Society (RPS). Workforce and Wellbeing survey 2024 [Internet]. London: Royal Pharmaceutical Society (RPS); 2025. Available from: https://rcpharm.wpenginepowered.com/wp-content/uploads/2026/04/RPS-2024…

418. Hassell K, Seston EM, Schafheutle EI, Wagner A, Eden M. Workload in community pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: a review of the evidence: A review of workload in community pharmacies. Health Soc Care Community. 2011 Nov;19(6):561–75. doi:10.1111/j.1365-2524.2011.00997.x

419. Paloumpi E, Ozieranski P, Watson MC, Jones MD. Professional stakeholders’ expectations for the future of community pharmacy practice in England: a qualitative study. BMJ Open. 2023 Oct;13(10):e075069. doi:10.1136/bmjopen-2023-075069

420. NHS England, Department of Health and Social Care (DHSC). NHS England [Internet]. London, United Kingdom: NHS England; 2023. NHS England » Delivery plan for recovering access to primary care. Available from: https://www.england.nhs.uk/long-read/delivery-plan-for-recovering-acces…

421. The Impact of Pharmacy Closures on Health Inequalities: One Year On [Briefing paper] [Internet]. London: Company Chemists’ Association (CCA); 2023. (CCA Briefing Paper). Available from: https://thecca.org.uk/wp-content/uploads/2023/11/Impact-of-pharmacy-clo…

422. Karanikolos M, Tynkkynen L-K, Keskimäki I. Finland: Health System Summary, 2024 [Internet]. Copenhagen: European Observatory on Health Systems and Policies; WHO Regional Office for Europe; 2024. (Health System Summary). Available from: https://iris.who.int/server/api/core/bitstreams/0e64a5ce-25f5-495a-8e92…

423. Sääskilahti M. Selvitys apteekkien farmaseuttisen neuvonnan sisällöstä ja dokumentoinnista / Study on the content and documentation of medication counseling in community pharmacies [Internet]. Helsinki: Sosiaali- ja terveysministeriö; 2025 Feb. (Sosiaali- ja terveysministeriön raportteja ja muistioita). Report 2025:9. Available from: https://julkaisut.valtioneuvosto.fi/server/api/core/bitstreams/dd6ca845…

424. Välimäki K. Medicines Policy 2020: Towards Efficient, Safe, Rational and Cost-Effective Use of Medicines [Government publication] [Internet]. Helsinki: Ministry of Social Affairs and Health (Finland); 2011. (Publications of the Ministry of Social Affairs and Health). Government publication 2011:10eng. Available from: https://julkaisut.valtioneuvosto.fi/server/api/core/bitstreams/1f27121d…

425. Rajaniemi S. Lääkehoidon ohjauksen kehittäminen: Selvityshenkilön raportti [Internet]. Helsinki: Sosiaali- ja terveysministeriö (STM); 2023. Available from: https://stm.fi/documents/1271139/2013549/Selvitys+SR+15.1.23_final.pdf/…

426. Rosenberg S, Södergård B, Rosenholm J, Rauha JP. Sustainability challenges concerning the effects of high-priced drugs on the day-to-day operations of community pharmacies in Finland. Eur J Pharm Sci. 2024 Aug;199:106816. doi:10.1016/j.ejps.2024.106816

427. Kehittää F, Informoi AJ. Lääketaksan, apteekkimaksun ja apteekkiveron kehittäminen Suomessa: Selvitys muutosehdotuksista, muutosten esteistä ja mahdollisista muutostekijöistä [Internet]. Kuopio: Lääkealan turvallisuus- ja kehittämiskeskus Fimea; 2021. (Fimea kehittää, arvioi ja informoi). Report no.: 1/2021. Available from: https://fimea.fi/documents/147152901/159465590/KAI+1+2021+Apteekkiveron…

428. Laakso J, Kallio S, Airaksinen M, Dimitrow M. Identifying patient data that should be available in community pharmacies for statutory dispensing and providing clinical pharmacy services: A Delphi study. Explor Res Clin Soc Pharm. 2026 Jun;22:100716. doi:10.1016/j.rcsop.2026.100716

429. Kari H, Kortejärvi H, Laaksonen R. Developing an interprofessional people-centred care model for home-living older people with multimorbidities in a primary care health centre: A community-based study. Explor Res Clin Soc Pharm. 2022 Mar;5:100114. doi:10.1016/j.rcsop.2022.100114

430. Light | Information about the program [Internet]. 2022 Feb 23 [cited 2026 Jun 3]. Available from: https://valo.apteekki.fi/information-in-english/

431. Alanne EE, Aarnio E, Linden K, Timonen J, Hämeen-Anttila K. Patient knowledge and acceptance of the upcoming automatic substitution of biological medicines in community pharmacies: survey of Finnish patients with inflammatory bowel disease and psoriasis. BMC Health Serv Res. 2025 Jul 3;25(1):905. doi:10.1186/s12913-025-13017-9

432. Hirvonen J, Salminen O, Vuorensola K, Katajavuori N, Huhtala H, Atkinson J. Pharmacy Practice and Education in Finland. Pharmacy. 2019 Feb 23;7(1):21. doi:10.3390/pharmacy7010021

433. Tahvanainen H, Voipio-Pulkki LM, Hämeen-Anttila K, Närhi U, Mäntyranta T, Holmström AR, et al. Drawing up the public national Rational Pharmacotherapy Action Plan as part of social and health services reform in Finland: a bottom-up approach involving stakeholders. BMC Health Serv Res. 2024 May 16;24(1):631. doi:10.1186/s12913-024-11068-y

434. Apteekkijärjestelmän kehittäminen – Nykytilan arviointi ja ehdotuksia jatkotoimenpiteiksi [Internet]. Available from: https://www.edilex.fi/ministerioiden_julkaisut/33285.pdf

435. Awanic Oy. Reporting System for Safety Incidents in Health Care Organizations. HaiPro [Internet]. [cited 2026 Jun 3]. Available from: https://awanic.fi/haipro/eng/

436. Kortejärvi H, Kunnamo I. Ehdotuksia lääkehoidon kokonaisuuden hallintaan ja optimointiin [Internet]. Helsinki: Sosiaali- ja terveysministeriö; 2019 Mar. Available from: https://stm.fi/documents/1271139/3206721/Ehdotuksia+l%C3%A4%C3%A4kehoid…

437. The Association of Finnish Pharmacies. Annual Review 2022 [Internet]. Helsinki; 2023. Available from: https://www.apteekkariliitto.fi/wp-content/uploads/2024/06/annual-revie…

438. Kallio S, Kumpusalo-Vauhkonen A, Järvensivu T, Mäntylä A, Pohjanoksa-Mäntylä M, Airaksinen M. Towards interprofessional networking in medication management of the aged: current challenges and potential solutions in Finland. Scand J Prim Health Care. 2016 Oct;34(4):368–76. doi:10.1080/02813432.2016.1249055

439. Kanninen J, Toivo T, Airaksinen M, Holm A, Savela E, Dimitrow M, et al. Collaborative medication reviews in community pharmacies—Drug‐related problems and the process of communicating them with physicians: A retrospective validation study. Health Sci Rep. 2024 Mar;7(3):e1971. doi:10.1002/hsr2.1971

440. Sosiaali- ja terveysministeriö. Näkökulmia lääkehoitoon ja lääkkeiden jakeluun liittyvistä muutostarpeista [Internet]. Helsinki: Sosiaali- ja terveysministeriö; 2019 Jan. (Sosiaali- ja terveysministeriön raportteja ja muistioita). Report 2019:5. Available from: https://julkaisut.valtioneuvosto.fi/server/api/core/bitstreams/b7c739ae…

441. Suomen Apteekkariliitto. Pharmacies in welfare areas / Apteekit hyvinvointialueilla [Internet]. Helsinki: Suomen Apteekkariliitto; 2025. (Kohti aluevaaleja 2025). Available from: https://www.apteekkariliitto.fi/wp-content/uploads/2025/01/SAL_Kohti_al…

442. Finnish Government. A Strong and Committed Finland: Programme of Prime Minister Petteri Orpo’s Government, 20 June 2023 [Internet]. Helsinki, Finland: Finnish Government; 2023. (Publications of the Finnish Government). Report 2023:60. Available from: https://julkaisut.valtioneuvosto.fi/server/api/core/bitstreams/ad4dc8fd…

443. Rosenberg S, Andtfolk M, Hägglund S, Wingren M, Nyholm L. Social robots counselling in community pharmacies – Helping or harming? A qualitative study of pharmacists’ views. Explor Res Clin Soc Pharm. 2024 Mar;13:100425. doi:10.1016/j.rcsop.2024.100425

444. Peltoniemi T, Suomi R, Peura S, Lähteenoja MNY. Electronic prescription as a driver for digitalization in Finnish pharmacies. BMC Health Serv Res. 2021 Dec;21(1):1017. doi:10.1186/s12913-021-07003-0

445. Hämeen-Anttila K, Mikkola H, Kokko M, Sinnemäki J, Reinikainen L. Selvitys apteekkien lakisääteiseen lääkeneuvontaan kuuluvista sisältökokonaisuuksista [Internet]. Helsinki, Finland: Sosiaali- ja terveysministeriö (Ministry of Social Affairs and Health, Finland); 2022 Nov [cited 2026 May 18]. (Sosiaali- ja terveysministeriön raportteja ja muistioita). Report 2022:24. Available from: https://julkaisut.valtioneuvosto.fi/server/api/core/bitstreams/ceed2c18…

446. OECD; European Observatory on Health Systems and Policies; European Commission. State of Health in the EU: Finland Country Health Profile 2025 [Internet]. OECD; European Observatory on Health Systems and Policies; European Commission; 2025. (State of Health in the EU). Available from: https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/12/c…

447. Mäkinen E, Taimi AK, Sandler C, Schoultz A, Holmström AR. Engaging Community Pharmacies in Promoting Outpatient Medication Safety – Identifying and Prioritizing Research Needs by Modified Nominal Group Technique. Risk Manag Healthc Policy. 2025 Jan;Volume 18:1–18. doi:10.2147/RMHP.S483642

448. Tahvanainen H, Kuitunen S, Holmström AR, Airaksinen M. Integrating medication risk management interventions into regular automated dose dispensing service of older home care clients – a systems approach. BMC Geriatr. 2021 Dec;21(1):663. doi:10.1186/s12877-021-02607-x

449. Finnish Medicines Agency Fimea. Rational Use of Medicines Through Information and Guidance: Medicines Information Services: Current State and the Strategy for 2020 [Internet]. Helsinki, Finland: Finnish Medicines Agency Fimea; 2012. (imea Develops, Assesses and Informs). Report Serial Publication 1/2012. Available from: https://www.julkari.fi/server/api/core/bitstreams/9ace39b8-7798-426b-a7…

450. Jalkanen K, Aarnio E, Lavikainen P, Lindström J, Peltonen M, Laatikainen T, et al. Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis. BMC Health Serv Res. 2021 Dec;21(1):916. doi:10.1186/s12913-021-06948-6

451. Peny JM. French Retail Pharmacies: 2019–2023 Perspectives [Internet]. Paris, France: Smart Pharma Consulting; 2020 Jan. (The Smart Pharma Business Papers – Position Paper). Available from: https://smart-pharma.com/wp-content/uploads/2020/01/French-retail-pharm…

452. Caisse Nationale de l’Assurance Maladie (CNAM). Ameli.fr [Internet]. Assurance Maladie; 2025 [cited 2026 May 6]. Les missions du pharmacien de proximité. Available from: https://www.ameli.fr/assure/sante/medicaments/missions-pharmacien

453. Haute Autorité de Santé (HAS). Élargissement des compétences en matière de vaccination des infirmiers, des pharmaciens et des sages-femmes : Second volet, enfants et adolescents de moins de 16 ans [Internet]. Saint-Denis La Plaine, France: Haute Autorité de Santé (HAS). Available from: https://www.has-sante.fr/upload/docs/application/pdf/2022-06/recommanda…

454. Direction de l’information légale et administrative / Service-Public.fr. Service-Public.fr [Internet]. Direction de l’information légale et administrative, Premier ministre; [cited 2026 May 2]. Amandelontsteking en blaasontsteking: Apothekers mogen onder bepaalde voorwaarden antibiotica zonder recept verstrekken. Available from: https://www.service-public.gouv.fr/particuliers/actualites/A17229

455. CNOP [Internet]. [cited 2026 Jun 2]. Les tests rapides d’orientation diagnostique (TROD) et d’évaluation autorisés à l’officine. Available from: https://www.ordre.pharmacien.fr/je-suis/pharmacien/pharmacien/mon-exerc…

456. OECD; European Observatory on Health Systems and Policies. Country Health Profile 2025: France [Internet]. Paris / Brussels: OECD; European Observatory on Health Systems and Policies; 2025. (State of Health in the EU). Available from: https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/12/c…

457. Peny JM. Economics of French Retail Pharmacies: What to Know & Understand to Better Decide [Internet]. Paris, France: Smart Pharma Consulting; 2024. (Market Insights Series). Available from: https://smart-pharma.com/wp-content/uploads/2024/11/Economics-of-French…

458. Peny JM. The French Pharma Market 2024–2029: Strategic Implications for Pharma Companies [Internet]. Paris, France: Smart Pharma Consulting; 2025. Available from: https://smart-pharma.com/wp-content/uploads/2025/01/French-Pharma-Marke…

459. Piraux A, Angibaud M, Nizet P, Navas D, Sallenave-Namont C, Prot-Labarthe S, et al. Factors influencing French community pharmacists’ willingness to participate in research projects: a mixed method study. BMC Prim Care. 2023 Nov 3;24(1):229. doi:10.1186/s12875-023-02163-w

460. Mongaret C, Daguet-Gallois A, Chopard V, Aubert L, Lestrille A, Malblanc S, et al. Freins et leviers à la réalisation des bilans partagés de médication en officine : retour sur une expérimentation dans la région Grand Est. Ann Pharm Fr. 2021 Mar;79(2):119–24. doi:10.1016/j.pharma.2020.10.009

461. Bardet JD, Combe J, Tanty A, Louvier P, Granjon M, Allenet B. Optimizing work in community pharmacy: What preferences do community pharmacists and pharmacy technicians have for a better allocation of daily activities? Explor Res Clin Soc Pharm. 2025 Mar;17:100549. doi:10.1016/j.rcsop.2024.100549

462. Barat E, Pouant C, Soubieux A, Arrii M, Bardet JD, Chenailler C, et al. État des lieux de la mise en place en France des entretiens pharmaceutiques en officine : analyse des réponses issues d’un questionnaire. Therapies. 2024 Jul;79(4):443–51. doi:10.1016/j.therap.2023.11.010

463. Ranchon F, Chanoine S, ANEPC Pedagogical Committee, Dupuis A, Grimandi G, Sève M, et al. Pharmacy Education and Clinical Pharmacy Training in France. Pharmacy. 2024 Oct 29;12(6):161. doi:10.3390/pharmacy12060161

464. Ministry of Health, Labour and Welfare (MHLW). Overview of Medical Service Regime in Japan [Internet]. Tokyo, Japan: Ministry of Health, Labour and Welfare (MHLW); 2012. Available from: https://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/dl/01_eng.pdf

465. C2H｜Center for Outcomes Research and Economic Evaluation for Health [Internet]. [cited 2026 Jun 3]. Price setting of medicines and medical devices. Available from: https://c2h.niph.go.jp/en/assessment/price-setting/

466. ‘Visie op de apotheek voor patiënten’ – Van ‘Apotheek in de buurt van het ziekenhuis’ naar ‘Familieapotheek’ en vervolgens naar ‘Buurtapotheek’ – is geformuleerd | Persbericht | Ministerie van Volksgezondheid, Arbeid en Welzijn [Internet]. [cited 2026 May 20]. Available from: https://www.mhlw.go.jp/stf/houdou/0000102179.html

467. Japan Health Policy NOW – Cost Control [Internet]. [cited 2026 Jun 3]. Available from: https://japanhpn.org/en/finan3/

468. Ministry of Health, Labour and Welfare. Guidebook on Insurance Coverage for Medical Devices and In Vitro Diagnostics [Guidebook] [Internet]. Tokyo, Japan: Ministry of Health, Labour and Welfare; 2024. Available from: https://www.mhlw.go.jp/content/10800000/001564622.pdf

469. Fujita K, Sato N, Okizaki A, Endo R, Taguchi M, Hilmer SN, et al. Pharmacist-Led Deprescribing Interventions for Older Adults with Polypharmacy: A Retrospective Cohort Study of Community Pharmacy Practice in Japan. Drugs Aging. 2026 Feb;43(2):203–10. doi:10.1007/s40266-025-01275-5

470. Iketani R. Effectiveness of the kakaritsuke-yakuzaishi (family pharmacist) system for underage individuals in Japan: a cohort study using a health insurance claims database. BMC Health Serv Res. 2025 Sep 2;25(1):1182. doi:10.1186/s12913-025-13358-5

471. Ministry of Health, Labour and Welfare (MHLW). かかりつけ薬剤師・薬局の評価について (Evaluation of Family Pharmacists and Family Pharmacies) [Internet]. Tokyo, Japan: Ministry of Health, Labour and Welfare (MHLW); 2019. Available from: https://www.mhlw.go.jp/content/12404000/000566794.pdf

472. Sekiya S, Tanaka R, Iijima H, Nakano Y, Miyazaki S, Toyomi A, et al. A Nationwide Survey on Medication Follow-up Care by Community Pharmacists: From The Japanese Nationwide Pharmacy Collaboration Survey in 2023. YAKUGAKU ZASSHI. 2024 Aug 1;144(8):805–13. doi:10.1248/yakushi.24-00016

473. PR-website voor familieapotheken en apotheken met gezondheidszorgondersteuning. [Internet]. [cited 2026 May 29]. Available from: https://www.nichiyaku.or.jp/kakaritsuke/

474. Taguchi R, Okada A, Tsuchiya‐Ito R, Kitamura S, Ishikawa T, Hamada S. Continuity of Visiting Pharmacist Services and Factors Related to Service Discontinuation Among Older Adults in Japan: A Retrospective Cohort Study. Pharmacol Res Perspect. 2025 Aug;13(4):e70152. doi:10.1002/prp2.70152

475. Nakagawa S, Kume N. Pharmacy Practice in Japan. Can J Hosp Pharm. 2017 Jun 30;70(3). doi:10.4212/cjhp.v70i3.1663

476. Iwata H, Kirihara T, Kobayashi N, Nakamura Y, Koike T, Yamaura K. Community Pharmacists’ Attitudes and Experiences Regarding the Promotion of Vaccinations in Japan. Keio J Med. 2026;2025-0007-OA. doi:10.2302/kjm.2025-0007-OA

477. 検体測定室等について [Internet]. [cited 2026 Jun 1]. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000098580.html

478. NIHON CHOUZAI [Internet]. [cited 2026 Jun 2]. Nihon Chouzai Launches In-house Developed ‘Nihon Chouzai Online Pharmacy Service’ and Begins Operating an Online Medication Guidance System at Its Pharmacies across the Country. Available from: https://www.nicho.co.jp/en/news/20200901_nr1/

479. Metropolitaans Instituut voor Volksgezondheid van Tokio » Over het systeem van buurtapotheken en apotheken verbonden aan gespecialiseerde medische instellingen [Internet]. [cited 2026 Jun 3]. Available from: https://www.tmiph.metro.tokyo.lg.jp/k_yakuji/renkeiyakkyoku/seido21/

480. Katsuta D, Ohashi Y, Kamimura M, Sunaga S, Asami Y, Kuriya K, et al. Status of Community Pharmacy Functions and Regional Medical Collaboration System Initiatives in Japan. Biol Pharm Bull. 2024 Dec 21;47(12):2092–100. doi:10.1248/bpb.b24-00316

481. Shibata Y, Itoh H, Matsuo H, Nakajima K. Differences in Pharmaceutical Intervention Triggers for the Optimization of Medication by Patient Age: A University Hospital Study. Biol Pharm Bull. 2021 Aug 1;44(8):1060–6. doi:10.1248/bpb.b21-00143

482. About the NDB | 6NCDB [Internet]. [cited 2026 Jun 3]. Available from: https://ndb6nc.jihs.go.jp/eng/outline/index.html

483. Fujita K, Kushida K, Okada H, Moles RJ, Chen TF. Developing and testing a set of quality indicators for pharmacist home visit services: A mixed methods study in Japan. Br J Clin Pharmacol. 2021 Apr;87(4):1940–52. doi:10.1111/bcp.14587

484. Digital Agency. Use of health insurance card in My Number Card｜Digital Agency [Internet]. 2026 [cited 2026 Jun 3]. Available from: https://www.digital.go.jp/en/policies/mynumber/insurance-card

485. 厚生労働省 医薬局総務課 (Ministry of Health, Labour and Welfare, Pharmaceutical Bureau, General Affairs Division). On the Role of Pharmacies and Pharmacists in Local Communities (8th Meeting) / 地域における薬局・薬剤師のあり方について（第8回） [Government discussion paper] [Internet]. Tokyo, Japan: Ministry of Health, Labour and Welfare (MHLW); 2024 Aug. (薬局・薬剤師の機能強化等に関する検討会 資料2 (Study Group on Strengthening the Functions of Pharmacies and Pharmacists, Document 2)). Available from: https://www.mhlw.go.jp/content/11121000/001291813.pdf

486. Nakagawa Y, Kato H, Iwamoto T. A qualitative study on the current status and problems of pharmacists in home healthcare from the viewpoint of care managers in medically underpopulated areas in Japan. J Pharm Health Care Sci. 2024 Nov 8;10(1):71. doi:10.1186/s40780-024-00395-1

487. Katsuta D, Kamimura M, Kuriya K, Yamada T, Masuyama K, Kitagaki K. Survey on the Current Status of the Regional Medical Collaboration System and Community Pharmacy Functions in Tokyo [Internet]. 2024. Available from: http://www.jscp.info/journal/img/pdf115.pdf

488. Suzuki S, Okada H, Tsuyuki RT, Nishikawa Y. Pharmacist accessibility for non-native Japanese speakers. Can Pharm J Rev Pharm Can. doi:10.1177/17151635241305375 PubMed Central PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC11748378/.

489. Kaoru K, Tetsuharu O. Opening of outsourcing medication dispensing and increasing clinical services in community pharmacy in Japan: Pharmacists’ impressions and opinions, based on a nationwide internet-based survey. 在宅薬学 [Internet]. 2023;10(1). Available from: https://www.jstage.jst.go.jp/article/jjcmps/10/1/10_41/_pdf

490. Hirota N, Okamura N. The Japanese Community Pharmacists’ Perceptions of the Health Support Pharmacy System. Pharmacol Amp Pharm. 2020;11(04):55–70. doi:10.4236/pp.2020.114006

491. Ministry of Health, Labour and Welfare (MHLW), Japan. About Certified Pharmacies (Community Collaboration Pharmacies and Health Promotion Support Pharmacies) / 認定薬局 （地域連携薬局、健康増進支援薬局）について) [Internet]. Tokyo, Japan: Ministry of Health, Labour and Welfare (MHLW), Japan; 2025 May. Available from: https://www.mhlw.go.jp/content/11121000/001510657.pdf

492. 厚生労働省 (Ministry of Health, Labour and Welfare). Guidelines for Specimen Testing Laboratories / 検体測定室に関するガイドラインに係る疑義解釈集 [Internet]. Tokyo, Japan: 厚生労働省医政局地域医療計画課 医療関連サービス室; 2023. Available from: https://www.mhlw.go.jp/content/10800000/001115854.pdf

493. Jin’o Y, Ushikai M, Komaki Y, Masuda K, Horiuchi M. Involvement of community pharmacy pharmacists in fecal immunochemical test screening without government support in Japan. Abbas S, editor. PLOS One. 2025 May 23;20(5):e0322879. doi:10.1371/journal.pone.0322879

494. Ministerie van Volksgezondheid, Welzijn en Sport. Aanvullend Zorg- en Welzijnsakkoord [Internet]. Den Haag, Nederland: Ministerie van Volksgezondheid, Welzijn en Sport; 2025 Jul. Available from: https://www.lhv.nl/wp-content/uploads/2025/07/Aanvullend-Zorg-en-Welzij…

495. Ilgin Arslan, Julia Bes, Lisa Jansen, Marloes Meijer. De beweging naar een sterkere eerste lijn: Nulmeting ten behoeve van de monitoring van het Integraal Zorgakkoord [Internet]. Utrecht, Nederland: Nivel; 2024 Jun. Available from: https://open.overheid.nl/documenten/76f7d4e5-5d5d-46bb-a359-1cd8e059040…

496. Zorgvuldig Advies. Inzicht in de ramingen voor extramurale en intramurale geneesmiddelen en hulpmiddelen: Verdiepend onderzoek naar de onzekerheden in de ramingen [Onderzoeksrapport] [Internet]. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport (VWS); 2024 Jan. Available from: https://open.overheid.nl/documenten/ebe94986-badd-42e7-b475-5358e95764a…

497. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). KNMP-standpunt landelijk opererende internetapotheek [Internet]. Den Haag, Nederland: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). Available from: https://www.knmp.nl/sites/default/files/2021-12/KNMP%20Standpunt%20Inte…

498. Zorginstituut Nederland. Prestatiebeschrijvingen farmaceutische zorg, duiding in het kader van de zorgverzekering (update november 2022 over GDV) [Standpunt Zvw (SpZ)] [Internet]. Diemen, Nederland: Zorginstituut Nederland; 2023 Jan. Available from: https://www.zorginstituutnederland.nl/site/binaries/site-content/collec…

499. Heringa M, Vervloet M, Bakker-Verdoorn S, Bakker S. Optimaliseren van medicatiegebruik bij ouderen: Een evaluatie in opdracht van het ministerie van VWS [Internet]. Leiden / Utrecht, Nederland: SIR Institute for Pharmacy Practice and Policy; 2024 Feb. Available from: https://open.overheid.nl/documenten/0a741bbd-2b9d-4526-910b-e3863b1cfab…

500. Zorginstituut Nederland. Afwegingskader noodzakelijk te verzekeren zorg: Balanceren tussen eigen verantwoordelijkheid en solidariteit [Internet]. Diemen: Zorginstituut Nederland; 2023 Dec. Available from: https://www.zorginstituutnederland.nl/site/binaries/site-content/collec…

501. Prins A. Input voor commissiedebat over leefstijlpreventie [Internet]. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP); 2022 maart. Report AP 20220053 JE. Available from: https://www.knmp.nl/media/1248

502. van Dijk L, Vervloet M, Schackmann L, Heringa M, van de Steeg C, Lansink MO, et al. Samen werken aan medicatieveiligheid: implementatie van adviezen voor betere medicatieveiligheid in de praktijk [Internet]. Utrecht: Nivel; 2025. Available from: https://www.nivel.nl/sites/default/files/bestanden/1004666.pdf

503. Lelie-van Der Zande R, Koster ES, Teichert M, Bouvy ML. Barriers and facilitators for providing self-care advice in community pharmacies: a qualitative study. Int J Clin Pharm. 2023 Jun;45(3):758–68. doi:10.1007/s11096-023-01571-3

504. Sloeserwij VM, Zwart DLM, Hazen ACM, Poldervaart JM, Leendertse AJ, De Bont AA, et al. Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study. Int J Clin Pharm. 2020 Oct;42(5):1293–303. doi:10.1007/s11096-020-01075-4

505. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). Kwaliteitsindicatoren Farmacie: Openbare apotheken meting over 2025 [Internet]. Den Haag, Nederland: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP); 2025. Available from: https://www.knmp.nl/sites/default/files/2026-02/proef_4a_openbare_apoth…

506. Van Dijk, Liset. Samen werken aan medicatieveiligheid: implementatie van adviezen voor betere medicatieveiligheid in de praktijk [Internet]. Utrecht: Nivel; 2025. Available from: https://www.nivel.nl/sites/default/files/bestanden/1004666.pdf

507. Zilveren Kruis. Kwaliteitsbeleid 2025 Extramurale Farmacie [Internet]. Zilveren Kruis; 2024. Available from: https://www.zilverenkruis.nl/zorgaanbieders/zorgsoort/extramurale-farma…

508. Nivel. Medicatieoverdracht: ontwikkeling van indicatoren voor monitoring van de kwaliteit van overdracht van medicatiegegevens [Internet]. Utrecht, Nederland: Nivel. Available from: https://zoek.officielebekendmakingen.nl/blg-1198887.pdf

509. Agema F. Betreft Eerstelijns apotheekzorg [Internet]. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport (VWS); 2025 Jun. Report nos: 4103174-1081865-GMT. Available from: https://open.overheid.nl/documenten/9121a310-ec5a-4417-b678-0c7de036ea5…

510. Vervloet M, Post A, van Dijk L, Flinterman L. Knelpunten in de arbeidsmarkt openbare farmacie: een onderzoek onder werkgevers [Internet]. Utrecht: Nivel; 2025. Available from: https://www.nivel.nl/sites/default/files/bestanden/1004739.pdf

511. Dijk L van, Bouvy M, Bakker D de, Burgt S van der, Floor-Schreudering A. Samenwerking tussen huisarts en openbaar apotheker: stand van zaken en mogelijkheden voor de toekomst [Internet]. Utrecht: Nivel; 2016. Available from: https://www.nivel.nl/sites/default/files/bestanden/Samenwerking_huisart…

512. Bestuurlijke realisatietafel visie eerstelijnszorg. Realisatieagenda Visie Eerstelijnszorg 2030 [Internet]. Ministerie van Volksgezondheid, Welzijn en Sport / betrokken eerstelijnspartijen; 2024 Dec. Available from: https://www.knmp.nl/sites/default/files/2025-01/realisatieagenda_visie_…

513. Ministerie van Volksgezondheid, Welzijn en Sport. GALA: Gezond en Actief Leven Akkoord [Internet]. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport; 2023 Jan. Available from: https://open.overheid.nl/documenten/ronl-e8e739b2e77bf92b7bfed78d4569ae…

514. Schackmann L, Vervloet M, van Tuyl L, van Dijk L. Naar een versterking van de samenwerking binnen de extramurale farmaceutische zorg [Internet]. Utrecht, Nederland: Nivel; 2024. Available from: https://www.nivel.nl/sites/default/files/bestanden/1004541.pdf

515. Hazen A, Sloeserwij V, Pouls B, Leendertse A, De Gier H, Bouvy M, et al. Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care. Int J Clin Pharm. 2021 Oct;43(5):1155–62. doi:10.1007/s11096-021-01304-4

516. Stewart D, Maclure K, Newham R, Gibson-Smith K, Bruce R, Cunningham S, et al. A cross-sectional survey of the pharmacy workforce in general practice in Scotland. Fam Pract. 2019 Sep 19;cmz052. doi:10.1093/fampra/cmz052

517. NHS Greater Glasgow and Clyde (NHSGGC). A Framework Service Level Agreement for Locally Enhanced Pharmaceutical Care Services for Patients Receiving Discharge Medicines Following Hospital Discharge [Internet]. Glasgow, Scotland, UK: NHS Greater Glasgow and Clyde (NHSGGC); 2024 Feb. Report Version 7. Available from: https://www.communitypharmacy.scot.nhs.uk/media/8647/sla-v7-jan-2024.pdf

518. Organisations linked to the recommendations of this Review report [Internet]. [cited 2026 Jun 3]. Available from: https://www.gov.scot/publications/independent-review-medicines-homecare…

519. Chapter 1 The Vision [Internet]. [cited 2026 Jun 3]. Available from: https://www.gov.scot/publications/prescription-excellence-vision-action…

520. Community Pharmacy Scotland [Internet]. [cited 2026 Jun 1]. NHS Pharmacy First Plus. Available from: https://www.cps.scot/contractor-member/nhs-pharmacy-first-plus

521. Community Pharmacy Scotland [Internet]. [cited 2026 Apr 29]. Core Services. Available from: https://www.cps.scot/core-services

522. Pharmacy services in Scotland. NHS inform [Internet]. [cited 2026 Jun 3]. Available from: https://www.nhsinform.scot/care-support-and-rights/nhs-services/pharmac…

523. Community Pharmacy Scotland [Internet]. [cited 2026 May 27]. Public Health Service. Available from: https://www.cps.scot/public-health-service

524. Community Pharmacy Scotland [Internet]. [cited 2026 May 28]. Medicines Care and Review. Available from: https://www.cps.scot/medicines-care-and-review

525. Independent prescribing, consultation and clinical assessment skil [Internet]. [cited 2026 Jun 3]. Available from: https://www.nes.scot.nhs.uk/our-work/pharmacy/independent-prescribing-c…

526. Community Pharmacy Scotland [Internet]. [cited 2026 Jun 1]. PCA(P)(2019)4 - Quality Improvement Activity. Available from: https://www.cps.scot/latest-news/pcap201904

527. Scottish Government. Prescription for Excellence: A Vision and Action Plan for the Right Pharmaceutical Care through Integrated Partnerships and Innovation [Internet]. Edinburgh: Scottish Government. Available from: https://www.gov.scot/binaries/content/documents/govscot/publications/st…

528. National Services Scotland [Internet]. [cited 2026 Jun 3]. Practitioner Services Directorate and Primary Care Contractor Finance Data Protection Notice. Available from: https://www.nss.nhs.scot/publications/practitioner-services-directorate…

529. National Services Scotland [Internet]. [cited 2026 Jun 3]. Guidance on the Pharmacy Care Record (PCR). Available from: https://www.nss.nhs.scot/pharmacy-services/pharmacy-care-record-pcr/gui…

530. Scottish Government. Primary care services [Internet]. Edinburgh: Scottish Government; [cited 2026 May 16]. Pharmacy. Available from: https://www.gov.scot/policies/primary-care-services/pharmacy/

531. NHS Scotland Governance [Internet]. [cited 2026 Jun 3]. Available from: https://www.nhs.scot/

532. Stewart F, Caldwell G, Cassells K, Burton J, Watson A. Building capacity in primary care: the implementation of a novel ‘Pharmacy First’ scheme for the management of UTI, impetigo and COPD exacerbation. Prim Health Care Res Dev. 2018 Nov;19(6):531–41. doi:10.1017/S1463423617000925

533. Community Pharmacy Scotland [Internet]. [cited 2026 Jun 3]. GP Records Access in NHS England. Available from: https://www.cps.scot/latest-news/gp-records-access-in-nhs-england

534. McLean MA, Forsyth P, Boyter AC. Pharmacists’ views on barriers and enablers to the implementation of advanced pharmacist prescribing in Scotland: a qualitative study using normalisation process theory. Int J Clin Pharm. 2025 Oct 6. doi:10.1007/s11096-025-02021-y

535. Lowrie R, Stock K, Lucey S, Knapp M, Williamson A, Montgomery M, et al. Pharmacist led homeless outreach engagement and non-medical independent prescribing (Rx) (PHOENIx) intervention for people experiencing homelessness: a non- randomised feasibility study. Int J Equity Health. 2021 Dec;20(1):19. doi:10.1186/s12939-020-01337-7

536. Scottish Government. NHS Pharmacy First Scotland: Equality Impact Assessment – Results [Internet]. Edinburgh: The Scottish Government; 2020. Available from: https://www.gov.scot/binaries/content/documents/govscot/publications/im…

537. New steps for pharmacists to access patient records [Internet]. [cited 2026 May 29]. Available from: https://healthandcare.scot/default.asp?page=story&story=4097

538. Protected learning time (PLT). Royal College of Pharmacy [Internet]. [cited 2026 Jun 3]. Available from: https://www.rcpharm.org/policies/protected-learning-time-plt/

539. Workforce Policies Programme | NHS Scotland [Internet]. [cited 2026 May 18]. Available from: https://workforce.nhs.scot/about/workforce-policies-programme/

540. Primary and Community Care [Internet]. [cited 2026 Jun 1]. Available from: https://www.gov.scot/publications/nhs-recovery-plan-2021-2026-annual-pr…

541. 4 Manageable Workload [Internet]. [cited 2026 Jun 3]. Available from: https://www.gov.scot/publications/gms-contract-scotland/pages/6/

542. NHS Scotland. Serial Prescribing FAQs for General Practice [Internet]. Edinburgh: NHS Scotland; 2021. Available from: https://www.nss.nhs.scot/media/1867/serial-prescribing-faqs-for-general…

543. National Services Scotland [Internet]. [cited 2026 Jun 3]. NHS Pharmacy First Scotland (PFS). Available from: https://www.nss.nhs.scot/pharmacy-services/pharmacy-services/nhs-pharma…

544. Community Pharmacy Scotland [Internet]. [cited 2026 Jun 3]. Local. Available from: https://www.cps.scot/local-services

545. Centers for Disease Control and Prevention. Collaborative Practice Agreements and Pharmacists’ Patient Care Services: A Resource for Pharmacists [Internet]. Atlanta, GA: Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/high-blood-pressure/media/pdfs/2024/04/Translationa…

546. Model Pharmacy Act/Rules. National Association of Boards of Pharmacy [Internet]. [cited 2026 Jun 3]. Available from: https://nabp.pharmacy/members/board-resources/model-pharmacy-act-rules/

547. Community-Based Pharmacy Solutions for All | CPESN [Internet]. [cited 2026 Jun 3]. Available from: https://cpesn.com/

548. Daly CJ, Iqbal DN, Coley K, Doucette WR. Scaling Community Pharmacy and Payer Partnerships for Patient Care: A Resource Guide for Payer Collaborations with Clinically Integrated Community Pharmacy Networks [Internet]. ACT (Academia-Community Transformation) Pharmacy Collaborative; 2025 Feb. Available from: https://communitypharmacyfoundation.org/resources/grant_docs/CPFGrantDo…

549. Abraham PA, Kannarkat JT, Qato DM. Reforming Markets to Strengthen Independent Pharmacies. JAMA Health Forum. 2025 Apr 4;6(4):e250142. doi:10.1001/jamahealthforum.2025.0142

550. Pharmacist and Pharmacy Technician Vaccination Authority. NASPA [Internet]. 2025 Jan 3 [cited 2026 Jun 3]. Available from: https://naspa.us/resource/2024-pharmacist-immunization-authority/

551. National Community Pharmacists Association (NCPA), National Alliance of State Pharmacy Associations (NASPA). A Guide to Implementing Point-of-Care Testing Services in Community Pharmacy [Internet]. Alexandria, Virginia, USA: National Community Pharmacists Association (NCPA) Innovation Center & National Alliance of State Pharmacy Associations (NASPA); 2023. Available from: https://ncpa.org/sites/default/files/2024-02/poct-implementation-guide…

552. Centers for Disease Control and Prevention (CDC). Pharmacist-Provided Medication Therapy Management in Medicaid [Internet]. Atlanta, GA: Centers for Disease Control and Prevention (CDC); 2021 May. Available from: https://www.cdc.gov/cardiovascular-resources/media/MTM_in_Medicaid-508…

553. naspa. Idaho Prescribing Rules Go Live July 1, Pharmacies Are Ready. NASPA [Internet]. 2018 Jun 29 [cited 2026 Jun 3]. Available from: https://naspa.us/2018/06/29/idaho-prescribing-rules-go-live-july-1-phar…

554. Progressive Pharmacy Practice | Idaho State University [Internet]. [cited 2026 Jun 1]. Available from: https://www.isu.edu/pharmacy/prospective-students/infographic-pages/pro…

555. Kumar A, Ray AB, Blanchard C. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization. Health Res Policy Syst. 2022 Dec;20(1):1. doi:10.1186/s12961-021-00789-9

556. Casey T. Provider Status for Pharmacists | AMCP.org [Internet]. 2026 [cited 2026 Jun 3]. Available from: https://www.amcp.org/legislative-regulatory-position/provider-status-ph…

557. Telepharmacy Rules and Statutes [Internet]. Available from: https://rupri.public-health.uiowa.edu/publications/policybriefs/2020/Te…

558. Thornbury J, Marraffa J, McAllister D, Newsome L, Stine P, Vick E, et al. Report of the Task Force on the Regulation of Pharmacist Care Services [Internet]. Mount Prospect, Illinois, USA: National Association of Boards of Pharmacy (NABP); 2015. Available from: https://nabp.pharmacy/wp-content/uploads/2016/07/RegulationPharmacistCa…

559. National Association of Boards of Pharmacy. Report of the Task Force to Review Model Rules for the Practice of Pharmacy and Develop New Pharmacy Practice Model [Internet]. Mount Prospect, Illinois, USA: National Association of Boards of Pharmacy; 2023. Available from: https://nabp.pharmacy/wp-content/uploads/2024/12/Report-of-the-Task-For…

560. E-Prescribing Standards and Requirements | CMS [Internet]. [cited 2026 Jun 3]. Available from: https://www.cms.gov/medicare/regulations-guidance/electronic-prescribin…

561. eCarePlan [Internet]. [cited 2026 Jun 3]. Home. Available from: https://www.ecareplaninitiative.com/

562. Worrall C, Shirley D, Bullard J, Dao A, Morrisette T. Impact of a clinical pharmacist-led, artificial intelligence–supported medication adherence program on medication adherence performance, chronic disease control measures, and cost savings. J Am Pharm Assoc. 2025 Jan;65(1):102271. doi:10.1016/j.japh.2024.102271

563. National Council for Prescription Drug Programs (NCPDP). Pharmacist eCare Plan: Version 1.0. Guidance on the Use of the HL7 CDA Consolidated Templates for Clinical Notes R2.1 Care Plan [Internet]. Scottsdale, AZ: National Council for Prescription Drug Programs (NCPDP); 2016 Sep. Available from: https://www.ncpdp.org/NCPDP/media/pdf/Pharmacist-eCare-Plan.pdf

564. Schmidtke KA, Warholak T. Payment models and the sustainability of community pharmacy practice: a qualitative interview study with community pharmacists. J Pharm Policy Pract. 2025 Dec 31;18(1):2450018. doi:10.1080/20523211.2025.2450018

565. House Committee on Oversight and Accountability Staff. The Role of Pharmacy Benefit Managers in Prescription Drug Markets [Internet]. Washington, DC: House Committee on Oversight and Accountability Staff; 2024. Available from: https://oversight.house.gov/wp-content/uploads/2024/07/PBM-Report-FINAL…

566. McGivney MAS, Pope DD, Trygstad T. Unrealized potential and unrecognized value: Community‐based pharmacy practice is reinventing itself—Join the movement. JACCP J Am Coll Clin Pharm. 2019 Aug;2(4):330–4. doi:10.1002/jac5.1147

567. The Pharmacists’ Patient Care Process. JCPP [Internet]. [cited 2026 Jun 3]. Available from: https://jcpp.net/patient-care-process/

568. Speer K. State Options Addressing Access to Contraception [Internet]. National Conference of State Legislatures; 2023 Apr. Available from: https://documents.ncsl.org/wwwncsl/Health/Access-to-Contraception-v02.p…

569. Pham K. Alternative payment approaches for advancing comprehensive medication management in primary care. Pharm Pract. 2020 Dec 8;18(4):2238. doi:10.18549/PharmPract.2020.4.2238

570. Ali ZZ, Skouteris H, Pirotta S, Hussainy SY, Low YL, Mazza D, et al. Interventions to Expand Community Pharmacists’ Scope of Practice. Pharmacy. 2024 Jun 19;12(3):95. doi:10.3390/pharmacy12030095